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Abstract 
It is likely that the success of treatment techniques in increasing consumers’ sense of 
inclusion in treatment decision making and increasing the likelihood for improved 
treatment outcomes for individuals with severe and persistent mental illness depends on 
the presence of common trait variables, such as empowerment and treatment-specific 
efficacy and process variables, such as the therapeutic relationship and the use of a shared 
decision-making style.  To understand the relationships between these variables in 
individuals with serious mental illness (SMI), this study used an archival data set 
consisting of 396 adults with major depression and schizophrenia-spectrum disorders 
from Philadelphia area community mental-health centers.  Questions covered their 
experience of global empowerment, the amount of confidence they had in asking 
questions of their physicians, their sense of shared decision making, the quality of the 
alliance with their treatment providers, and their perceived treatment 
satisfaction/outcomes.  Hierarchical regression and multiple linear regression analyses 
were conducted to determine the relationship between the variables using the 
Empowerment Scale (ES), Working Alliance Inventory (WAI), Perceived Efficacy in 
Patient-Physician Interactions (PEPPI), Participatory Decision-Making Scale (PDMS), 
and their contribution to perceived treatment outcomes in individuals with serious mental 
illness, measured by the Mental Health Statistical Improvement Program Inventory 
(MHSIP).  Participants articulated greater treatment satisfaction outcomes in the presence 
of greater perceived global empowerment, greater perceived inclusion in treatment 
decision making, and greater perceived working alliance. Participants also articulated 
greater sense of shared decision making in the presence of greater empowerment and 
vi 
 
working alliance. Treatment outcomes and sense of inclusion in decision making were 
not significantly related to sense of treatment specific efficacy.  The results of this study 
indicate the need for greater understanding of how to increase the sense of empowerment 
of individuals with SMI, as well as the need for clinicians to develop greater skill at 
fostering a sense of inclusion and working alliance in treatment to ensure greater 
treatment outcome satisfaction.  
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Chapter 1: Introduction 
Statement of the Problem 
 Today, individuals with serious mental illnesses (SMI) have the opportunity, more 
than at any other time in the history of the treatment of mental illness, to participate in 
and guide the direction of their care (Anthony, 1993).  The clinicians who are providing 
the treatment have a responsibility to allow these individuals to exercise this right for 
inclusion and to begin to understand their role in helping consumers to do so (Warner, 
2009). Therefore, clinicians must seek to empower consumers in their ability to become 
active participants in their own treatment.  
Consumers’ empowerment was first operationally defined by Rogers, 
Chamberlin, Ellison, and Crean (1997).  This group of researchers, who were considered 
leaders in the self-help movement, was the first to apply the construct to individuals with 
SMI.  Their study suggested that programs should focus on increasing an individual’s 
self-esteem and self-efficacy, increase perceived power particularly by increasing 
financial resources, and decrease feelings of powerlessness in treatment (Rogers et al., 
1997).  Current empowerment theory, research, and interventions suggest individual 
well-being, along with the larger social and political environment, is a truer definition of 
the construct because the construct includes a focus on mental health that requires both 
mutual help from and the creation of a responsive community (Perkins & Zimmerman, 
1995).   Therefore, empowerment is best enhanced in an environment that seeks to 
respond to individuals with SMI (SMI)
1
 needs by increasing their sense of control in their 
                                                 
1     SMI is defined differently by different researchers.  For the purpose of this study, the sample included participants with the 
following diagnostic criteria: Individuals with a primary Axis I diagnosis of schizophrenia, a schizophrenia spectrum disorder, or 
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mental-health treatment.  Mental-health professionals who strive to empower their clients 
in their own mental-health care can be more confident that these individuals will be more 
likely to adhere to treatment recommendations that are made on their behalf (O’Brien, 
Fahmy, & Singh, 2009).  
 Similar to individuals with chronic health problems, such as diabetes or heart 
disease, individuals with SMI are known to have poor adherence to treatment 
recommendations, including medication regimens and attendance at appointments 
(O’Brien et al., 2009).  When these individuals fail to follow through with their scheduled 
appointments, they may experience an increase in symptoms of their illness, which can 
lead to a relapse, making more probable their need for treatment in the form of inpatient 
hospitalization.  This tendency to relapse represents a common spiral that ultimately 
results in wasted resources, both because of the cost of the missed outpatient services and 
the high expense of the inpatient hospitalization.  Some researchers have suggested that 
the current model of service provision is not conducive to improved client engagement in 
treatment (Anthony, 1993; Chamberlin, 2009). Researchers and consumer advocates, 
many of whom have been diagnosed with a mental illness themselves, have called for a 
change from the traditional medical treatment model to a more consumer-oriented and 
empowering model in an effort to improve engagement in the practices that will assist in 
their recovery (O’Brien et al., 2009). 
A large body of research exists that has investigated correlates of treatment 
outcomes. The amount of perceived self-efficacy has been shown to be highly correlated 
                                                                                                                                                 
major depression. For all future references, this document will use the term SMI, but please note that for this study it only refers to 
these three main diagnostic SMI subgroups.  In a later section, the participants will be more thoroughly described. 
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to an individual’s ability to recover from a mental illness (Maly, Frank, Marshall, 
DiMatteo, & Reuben, 1998).  The therapeutic alliance is another variable that has been 
reliably linked to treatment outcomes (Lehman et al., 2004; O’Brien et al., 2009; Smerud 
& Rosenfarb, 2008).  That is, with greater reported working alliance, there are greater 
reports of positive therapeutic outcomes (Smerud & Rosenfarb, 2008).  The converse is 
also true. In addition to therapeutic alliance, empowerment is increasingly becoming an 
important focus in enhancing consumer efficacy (Perkins & Zimmerman, 1995; Smerud 
& Rosenfarb, 2008).  Changing the focus from problem-centered to patient-centered 
interactions likely will result in a positive increase in reported therapeutic alliance, as will 
the style that the clinician/physician uses in making treatment decisions.  Determining the 
relationships among these constructs and using this information to guide treatment 
interventions will serve to improve treatment outcomes in general.  
Purpose of the Study 
This study attempted to uncover the relationships between consumer-reported 
levels of empowerment and working alliance, and their reported perceived self-efficacy, 
inclusion in treatment decision making, and treatment outcomes in the hopes of providing 
direction and guidance to provider training and program direction.  Moreover, this study 
will further the current literature and understanding of the nature and value of assisting 
consumers of mental-health services to engage actively in their mental-health treatment 
and experience recovery from their diagnosed psychiatric disability.   
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Relevancy of the Program Goals 
 This study addresses the program’s goal to produce practitioner-scholars who 
have an appreciation and comprehension of the broad and general knowledge base that 
informs the profession of psychology.  In addition, this study addresses the program’s 
goal of producing practitioner-scholars who are able to identify and understand issues of 
individual and cultural diversity.  Therapeutic alliance and empowerment are two 
important concepts in the provision of mental-health services.  They involve 
understanding the need to be sensitive to multicultural issues, as well as being responsive 
to, and gaining knowledge of, ethnically and racially different individuals.  This study 
accomplishes this goal by including a review of the literature that focuses on the 
historical foundations of consumer empowerment, as well as on the current consumer 
empowerment movement.  Finally, this study serves as an endeavor to increase awareness 
of the greater need for the evaluation of current therapeutic interventions, furthering the 
advocacy efforts to change current policies for the provision of services for individuals 
diagnosed with SMI. 
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Chapter 2: Literature Review 
 The prevalence of mental illness in the United States is estimated to affect 26.2% 
of Americans ages 18 years and older in a given year, according to a study that measured 
the prevalence, severity, and comorbidity of mental illness in America (Kessler, Chiu, 
Demler, & Walters, 2005).  This statistic, when applied to the 2004 U. S. Census data, 
suggests that a total of approximately 57.7 million individuals are diagnosed in a given 
year with some type of mental health problem (DeNavas-Walt, Proctor, & Hill Lee, 
2005).  However, though mental disorders are somewhat common in the United States, 
the greatest burden of mental illness belongs to those who are diagnosed with SMI 
(Kessler et al., 2005).  According to one study, SMI is associated with an annual loss of 
earnings totaling $193.2 billion (Insel, 2008; Kessler et al., 2008).  It is estimated that 
only a small proportion, approximately 1 in 17, or 6%, of U. S. residents fall into this 
more serious category (Kessler et al., 2005).   
Changing Focus in Treatment 
Treatment paradigms have shifted from a focus on diagnosing and treating the 
mental illness to an ideology that seeks to assist individuals with mental disorders in 
achieving their highest level of wellness (Chamberlin, 2009; Warner, 2009).  This shift 
has become a focal point in the development of new treatment approaches as more 
individuals with SMI are able to regain levels of functioning they experienced prior to 
their diagnosis.  In fact, consumers with SMI have also been able to gain higher skill 
levels post diagnosis (Chamberlin, 2009).  One example of a diagnosis that falls under the 
category of SMI is schizophrenia.  Schizophrenia was once thought to be a lifelong and 
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chronic prognosis.  However, a study by Harding, Brooks, Ashikaga, Strauss, & Brier 
(1987) suggested that there was the potential for different outcomes in the trajectory of 
schizophrenia.  The study followed 82 individuals with schizophrenia for 20 to 25 years 
and indicated a great amount of heterogeneity in the functional outcomes of these 
individuals.  Specifically, the downward trajectory that was once thought inevitable by 
treating clinicians was dispelled, as the study indicated that 73% of the participants led 
moderate to very full lives (Harding et al., 1987).  Furthermore, 81% of participants were 
able to meet their basic daily needs, and 68% of the participants denied the presence of 
symptoms or experienced only slight symptomatology (Harding et al., 1987).  
The understanding that individuals with SMI can live fulfilling lives and have 
greater input in their treatment planning has been a starting point for the consumer 
movement in America, a type of grass roots effort led by individuals diagnosed with 
psychiatric disabilities.  This movement began to form in early 1970, during a time when 
important decisions about funding and provision of mental-health care were being 
decided by state and federal legislators.  Former consumers of mental-health treatment 
services across the nation began to gather together with the goal of developing a greater 
awareness of patients’ rights and their inclusion and influence in treatment planning.  The 
continued focus of these groups today is to bring attention to the lack of inclusion of the 
individual in the actual treatment decision-making process (Warner, 2009).   
The World Health Organization (WHO) suggested that the focus of change should 
be on mental health, rather than on mental illness.  Mental health is defined as a state of 
complete mental, physical, and social well-being (World Health Organization [WHO], 
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2005).  In this definition, the focus is not only on targeting and eradicating the symptoms, 
but also on improving individuals’ life experiences (WHO, 2005).   
However, the statistics discussed at the opening of this chapter indicate that SMI 
remains a significant public-health problem and that treatment providers are still in the 
beginning stages of understanding all the factors that contribute to individuals’ 
recoveries. Therefore, the question remains: How do individuals diagnosed with SMI get 
better, and what variables are important in fostering individuals’ desires and abilities to 
recover from their mental illnesses? This chapter will review the current understanding of 
the impact that the constructs of self-efficacy, empowerment, therapeutic alliance, and 
inclusion in treatment decision making have on individuals diagnosed with SMI under the 
larger umbrella of the mental-health transformation that is occurring across the nation.  A 
brief history of the changing treatment models will be reviewed in order to better 
understand how and why the provision of healthcare is changing.  Next will be a review 
of the four previously mentioned constructs that are gaining greater attention in the field 
as being related to focus of the transformation – namely, recovery from mental illness. 
Self-efficacy, an important construct of human agency and motivation, is reviewed in this 
context.  Following that will be a discussion of empowerment as a construct, a historical 
movement, and as a catalyst for mental-health recovery.  After the review of 
empowerment, the concept of therapeutic alliance and its role in recovery from diagnosed 
psychiatric disability will be reviewed and discussed.   Finally, information about the 
importance of physician’s inclusion of the client in decision making, in relationship to 
recovery from mental illness, is discussed.  Some of these constructs have been studied at 
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length and have a large body of support in the literature.  This study seeks to bring these 
constructs together in order to determine their contribution to the process of recovery in 
individuals with SMI.   
History of Changing Treatment Models 
Medical Model Versus Patient-Centered Care  
In the process of determining the best treatment for individuals with SMI, 
treatment approaches have progressed from using a medical or biological model to taking 
an approach that looks at the whole person and, furthermore, encourages the inclusion of 
the individual in his or her treatment.  The medical model has been rooted traditionally in 
the belief that the physician holds the knowledge and power in the relationship to make 
all of the treatment decisions for the individual seeking the treatment.  This approach to 
treatment largely continues to govern the order and timing of treatment in the behavioral-
health field today (Brown, Rempfer, & Hamera, 2008).  However, a growing consensus 
of consumers, consumer advocates, researchers, and clinicians considers the use of 
recovery-oriented and patient-centered approaches to individuals with SMI to be more 
effective (Brown et al., 2008).  Trinh, Moore, and Brendel (2008) proposed that the 
primary issue at the core of the traditional medical model is a debate about respecting 
clients’ autonomy versus achieving the best positive clinical results.  This achievement 
requires consideration of inclusion of individuals’ opinions and preferences in their care.   
According to Trinh et al. (2008), this construct can be conceptualized as physician 
“beneficence” (Trinh et al., 2008). Understanding a patient’s right to autonomy also 
requires respecting the right of an individual to refuse or choose a particular course of 
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treatment (Trinh et al., 2008).  It furthermore entails the individual’s right to lifestyle and 
treatment choices, given that he or she is able to give informed consent, can consider the 
options rationally, and can make consistent choices over time (Trinh et al., 2008).  
Caveats are put into place to ensure that, though there is respect for what might be a 
“poor” choice for a client, the treatment team can and should intervene to ensure that 
clients do no harm to him or herself or to others.  Thus, in the patient-centered model of 
care, the focus is on allowing the individual to increase his or her independence in choice 
of treatment planning.  Consumers of behavioral-health services are furthermore 
encouraged to be active participants in their treatment. Many of the defining components 
of patient-centered care were also emphasized in the significant paradigm shift that has 
occurred in the behavioral-health service field. Called the mental-health system 
transformation, the behavioral-health field has received considerable attention from 
consumers, advocates, and subsequently governing agencies calling for the drastic change 
and improvement in the delivery of services.  The following section reviews the recent 
changes to the behavioral-health system.  
The Transformation of the Mental-Health System 
 In 2001, President George W. Bush announced the development of the New 
Freedom Initiative (NFI) as a means to promote awareness of and increase access to 
employment and educational opportunities for individuals with disabilities (New 
Freedom Commission on Mental Health [NFCMH], 2003a). The NFI was also designed 
to increase access to community resources and other technologies for the purpose of 
assisting individuals’ full access to community life.  In other words, services were to be 
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established for individuals with disabilities that would allow for greater community 
integration (NFCMH, 2003a).  The development of the NFI was in part related to the 
1999 ruling in the Olmstead v. L.C. decision in which the Justices of the United States 
Supreme Court ruled, in line with the Americans with Disabilities Act, under Title II, that 
individuals with mental disabilities have the right to live in and receive treatment in the 
greater community instead of in institutional settings.  The landmark ruling also indicated 
that the community had a responsibility to develop resources for individuals with 
disabilities to ensure their successful adaptation and ability to thrive in their communities 
(NFCMH, 2003a).   
The findings from the NFI resulted in the development of the New Freedom 
Commission on Mental Health (NFCMH) in 2002. The charge of the NFCMH was to 
study the mental-health service delivery system in the United States for the purpose of 
making recommendations that would enable adults with SMI and children with serious 
emotional disturbances to be integrated with their communities.  In July of 2003, the NFC 
submitted the final report of the findings in their document entitled, Achieving the 
Promise: Transforming Mental Health Care in America (NFCMH, 2003b).  After a year 
of reviewing research and testimony, the NFC found that recovery from mental illness 
was a real possibility.  Under the guidelines for a transformed system, the NFCMH 
advised that recovery from mental illness was to be the goal of all treatment that is 
provided to individuals seeking treatment (NFCMH, 2003b).   
The NFCMH provided the following definition of recovery from mental illnesses: 
“Recovery refers to the process in which people are able to live, work, learn, and 
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participate fully in their communities” (NFCMH, 2003b, p. 7). Therefore, according to 
this definition, for some individuals recovery will include living a fulfilling life in the 
presence of a disability. For others, recovery will also include either a reduction or a 
remission of all symptoms.  By viewing recovery in this manner, hope for a meaningful 
life is increased.  Research has shown that hope is integral in an individual’s ability to 
recover (NFCMH, 2003a).   
The NFCMH noted, however, that system change was needed in order to combat 
the reality of a fragmented and disconnected mental health treatment delivery system.  
According to the Commission report, “In a transformed system, consumers and family 
members will have access to timely and accurate information that promotes learning, 
self-monitoring, and accountability” (NFCMH, 2003a, p. 8). Personalized care is a part of 
this guideline and is loosely defined as choosing which treatment providers will be on the 
consumer’s team, what the modality of treatment will be, and how appropriate healthcare 
will be provided.  Additionally, the report outlined a plan of action for individuals when 
first diagnosed with SMI.  According to the Commission, healthcare providers are 
charged with the duty of “develop[ing] an individualized plan of care for managing the 
illness” by collaborating with the consumer and with his or her families (NFCMH, 2003a, 
p. 8).  The NFCMH advised that the provision of all healthcare will include shared 
decision making and consumers collaborating in the treatment plan.     
The NFCMH indicated that three primary obstacles prevent individuals with 
psychiatric disabilities from receiving the care that they deserve.  These included “the 
stigma that surrounds mental illnesses, unfair treatment limitations and financial 
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requirements placed on mental health benefits in private health insurance, and the 
fragmented mental health service delivery system” (NFCMH, 2003b, p. 1). Based on 
these observed obstacles, one goal of the transformation of the mental-health system, 
therefore, is to reduce the stigma surrounding mental illness.  By making recovery the 
primary goal and outcome of mental-health treatment, the hope is that stigma will be 
reduced, reinforcing the hope of recovery for every person diagnosed with a mental 
illness.  The desired outcome of the transformation, according to the NFCMH, will allow 
for American consumers to seek mental healthcare when they need it, as the stigma 
surrounding mental illness and the need for treatment will be reduced or eliminated.  
In the 2002 report from the NFCMH, the onus of the responsibility for the 
observed deficits in the behavioral-health delivery system were not attributed solely to a 
lack of professionalism or compassion in the behavioral healthcare workers. Instead, the 
NFCMH suggested that the problems in the delivery of services were primarily caused by 
the lack of available effective and efficient community services on which people with 
SMI can count.  The suggestion was that the programs that were evaluated and found to 
be fragmented across levels of government and within many agencies needed to be 
retooled and better integrated into the community in order to provide the most effective 
treatment (NFCMH, 2003a).  However, while there is a dearth of adequate community 
resources that are targeted to ensure successful recovery for individuals with SMI, one 
can argue that the treatment providers who are making referrals to the available 
community resources lack the skills needed to build healthy working alliances with 
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individuals with SMI, thereby increasing their sense of hopelessness in their ability to 
recover.   
According to the NFCMH, two principles are involved in successfully 
transforming the delivery of behavioral-health services: (a) services and treatment must 
be consumer and family centered, and (b) treatment must focus not only on managing 
symptoms, but also on increasing the consumers’ ability to cope with the challenges of 
life, on facilitating recovery, and on building resilience (NFCMH, 2003a/b).  These 
principles reflect the need for treatment providers to consider the consequences of 
interactions with people with psychiatric disabilities, as providers may, in fact, be 
hindering their clients’ ability to recover.   
Substance Abuse & Mental Health Services Administration (SAMHSA) and 
Recovery 
In addition to the two previously mentioned guiding principles of a transformed 
mental health system, SAMHSA released the Federal Mental Health Action Agenda in 
2009, in which the President’s Executive Order 13263 of April 2002 listed five principles 
around which the NFCMH framed its work (SAMHSA, 2009; United States Department 
of Health and Human Services [UHHS], 2002).  The principles were designed to 
exemplify the overarching vision that is to shape the necessary work to change the system 
of behavioral healthcare.  The five principles include (a) The focus of the desired 
treatment outcomes will be to seek to attain each individual’s maximum level of 
recovery, as defined by the NFCMH (i.e., highest levels of employment, self-care, 
interpersonal relationships, and community integration); (b) All health and human service 
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providers, as well as both the public and private funding sources, will effectively manage 
and coordinate the needed behavioral- health treatment and delivery of services on a 
community level; (c) Behavioral healthcare will focus on ensuring that policies will 
maximize the usefulness of existing resources by increasing cost effectiveness and 
reducing unnecessary and burdensome regulatory barriers; (d) Research findings will be 
reviewed regularly for the purpose of determining how to most effectively influence the 
delivery of services; and, (e) The NFCMH will ensure that their recommendations will 
promote innovation, flexibility, and accountability at all levels of governing agencies 
while respecting the constitutional role of the States and Indian tribes (NFCMH, 
2003a/b). Clearly, transformation of this magnitude will require the restructuring of all 
behavioral-health delivery systems.  Additionally, the current and incoming behavioral-
health care workforce will require retraining in recovery-oriented principles in order to 
attain the goals established by the NFCMH and SAMHSA.      
 The NFCMH set forth six similar goals to aspire to in order to transform the 
mental-health treatment delivery system. The transformation requires developing a 
behavioral healthcare system in which Americans understand that: (a) mental health is 
essential to overall health; (b) mental healthcare is consumer and family driven; (c) 
disparities in mental-health services are eliminated; (d) early mental-health screening, 
assessment, and referral to services are common practice; (e) excellent mental healthcare 
is delivered and research is accelerated; and (f) technology is used to access mental 
healthcare and information.  In particular, the fifth listed goal suggests the need for 
further training of clinicians and physicians providing treatment to individuals with 
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psychiatric disability. Training will need to include a strong focus on using treatment 
approaches that have demonstrated effectiveness through empirical testing. 
 Based on the requisite changes that will need to be made to transform the 
provision of behavioral health treatment to be compliant with the recommended best 
practices for the delivery of treatment, it is important to conceptualize the constructs that 
correlate with an individual’s ability to recover.  The following sections discuss four 
correlates that appear to be highly important in the provision of treatment, and thus may 
make an individual with SMI more likely to maintain the focus and motivation required 
to gain and maintain recovery from the diagnosed psychiatric disability.  These constructs 
include self-efficacy, global empowerment, therapeutic alliance, and the physician’s use 
of a shared decision-making style. 
Self-Efficacy 
Self-Efficacy and Behavior 
Social cognitive theory explains human functioning through an interaction of 
reciprocal determinism (Bandura, 1986).  Individuals’ behaviors both influence and are 
influenced by their environments and by personal factors (Bandura, 1977; 1986).  Social 
Cognitive Theory involves an understanding of the feed-forward system of self-
regulation.  This system differs from other theories of behavioral control that are rooted 
in a negative feedback system, which merely attempts to prevent error (Bandura, 1986; 
Bandura & Locke, 2003).  Self-efficacy beliefs influence this system and are central to 
individuals’ successful completion of a behavior or goal, because self-efficacy beliefs 
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affect how individuals think, feel, behave, and motivate themselves (Bandura, 1986; 
2004).  
When considering the importance of self-efficacy and individuals with SMI, one 
can clearly see that individuals’ perceptions of their own abilities and their environmental 
conditions play a significant role in the way these individuals manage their mental illness.  
Therefore, when considering recovery from SMI, perhaps nothing is more essential to 
acting in ways that will positively affect their experience of mental illness than the belief 
in their capabilities to do so.  In order to better understand how this construct impacts the 
management of a mental illness, the following section reviews the definition of self-
efficacy.  Then, the effect of self-efficacy on specific healthcare behaviors is discussed.  
Definition of Self-Efficacy 
 Bandura (1994) defined self-efficacy as peoples’ beliefs about their capability to 
enact a certain behavior.  People must believe that they can produce expected levels of 
performance that influence the events that affect their lives, suggesting a positive 
relationship between individuals’ self-efficacy and their beliefs about their ability to cope 
in a given situation (Bandura, 1994).  Moreover, beliefs about self-efficacy affect how 
individuals think, feel, behave, and even motivate themselves in a given situation 
(Bandura, 1994).  Self-efficacy, then, is regarded as context- and task-specific in relation 
to a particular behavioral outcome (McCann, Clark, & Lu, 2008).  Self-efficacy is 
different from self-esteem, as the latter is considered to be a generalized sense of self-
worth (McCann et al., 2008).  Owing to its behavior-specific nature, self-esteem can be 
learned and enhanced upon through increasing attempts to complete goals and tasks 
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(Lorig & Holman, 1993).  It is not a personality trait that remains relatively stable 
throughout the lifespan, like self-efficacy (Lorig & Holman, 1993; McCann et al., 2008).  
 According to Bandura (1997), among the different mechanisms of human agency, 
a sense of personal efficacy is more central to one’s belief in the ability to exercise 
control over the events that affect one’s life.  Furthermore, he stated that regardless of 
any other factors that serve as guides and motivators for behavior, all are rooted in the 
core belief of one’s ability to achieve the desired effect by acting, or actually taking 
action, to meet a goal (Bandura, 1997; Benight & Bandura, 2004).  When this core 
element is not present, an individual has little incentive either to act or to persevere when 
tasks become difficult.  With taxing pursuits, individuals must judge their efficacy as 
sufficient both to sustain their motivation and task-oriented focus and to effectively 
manage any distressing emotional states and self-destructive thought patterns that may 
surface while seeking to meet their goal (Bandura & Locke, 2003).  These debilitating 
beliefs can impair the individual’s ability to execute the necessary activities related to the 
goal.  Beliefs in one’s ability to act in a way that will mitigate the experience of SMI will 
also affect the outcome of treatment.  The following section reviews the impact of self-
efficacy on motivation to manage illness and actual treatment outcomes. 
Self-Efficacy and Motivation for Healthcare Behaviors 
Bandura (1986) believed that beliefs in personal self-efficacy are the actual 
foundation of human agency.  He suggested that individuals are more likely to follow 
through on important healthcare behaviors if two overarching circumstances exist 
(Bandura, 1986; Moore, 1990).  First, individuals’ health beliefs must indicate that a 
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specific behavior will produce and result in the desired outcome (Moore, 1990).  For 
example, medication adherence in the population diagnosed with SMI is currently at 
50%, with a success rate for decreasing targeted symptoms estimated to be in a range 
from 5 to 25% (Corrigan, Liberman, & Engel, 1990; Lacro, Dunn, Dolder, Leckband, & 
Jeste, 2002; Warner, 2004).  In this example, the medications are not producing the 
desired or expected outcome.  Therefore, individuals may choose not to take the 
medication, as their expectation may be that the medication should be able to take away 
all of their symptoms.  Individuals are even more likely to stop taking their medications if 
they are also experiencing side effects from the treatment (Corrigan et al., 1990).   
The second condition that needs to be present in order to increase the likelihood 
that individuals will follow through on important healthcare behaviors is confidence in 
their ability to actually carry out a particular behavior or action sequence to achieve the 
desired and intended result (Moore, 1990).  These tasks could include scheduling and 
attending doctors’ appointments, remembering to drop off prescriptions for medications 
that are needed for their physical and mental health, and picking up medications from 
their pharmacies, to name only a few.  Each of these tasks requires a number of 
successive behaviors in order to be completed.  Individuals with SMI who have strong 
perceived self-efficacy are better able to address the many and oftentimes complex tasks 
that are required to maintain their physical and mental wellness (Corrigan et al., 1990; 
Lacro et al., 2002; Moore, 1990).   
It is not surprising, then, that individuals who do not feel capable of completing a 
task are not likely to attempt it.  They are also less likely to persevere in their efforts to 
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achieve the goal of the task.  With this in mind, one can understand that treatment 
outcomes are also impacted by the presence or deficiency of self-efficacy.  The following 
section reiterates the importance of self-efficacy on the outcome of treatment for 
individuals with medical and mental-health disorders.  
Self-Efficacy and Treatment Outcomes 
 Studies of self-efficacy have found this construct to be a powerful mediator of 
health behaviors and outcomes across many patient populations and health conditions 
(Aljasem, Peyrot, Wissow, & Rubin, 2001; Franks, Chapman, Duberstein, & Jerant, 
2009).  Regarding healthcare outcomes, correlation between self-efficacy and 
individuals’ beliefs that they are able and capable of performing at a level that will 
produce positive effects in their health has been found (McCann et al., 2008).  
Furthermore, studies have shown that peer-led interventions increase and strengthen self-
efficacy and result in positive changes in health behaviors and outcomes in individuals 
with chronic conditions (Warnecke, Morera, Turner, Mermelstein, Johnson, & Parson, et 
al., 2001).  However, few studies have reviewed longer term effects of these programs.  
Therefore, the effect of peer-led intervention programs on illness management self-
efficacy remains unclear (Franks et al., 2009).  
 Lorig et al. (1999) developed the most widely used and researched health care 
intervention known to enhance self-efficacy, known as the Chronic Disease Self 
Management Program (CDSMP).  This program provides participants with self-efficacy 
and skills training that is required to manage their chronic medical conditions, regardless 
of the diagnosis. The intervention seeks to enhance self-efficacy through mastering six 
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core self-management tasks.  The tasks include solving problems, making decisions, 
using resources, forming a positive relationship with the provider, making an action plan 
for health behavior change, and tailoring treatments to individual requests (Lorig et al., 
1999). The CDSMP used highly trained nonhealthcare providers, or participants’ peers, 
to deliver the intervention.  The results of a study designed to measure the program’s 
efficacy, when considering personality as a moderator variable, showed significant 
improvement in illness management self-efficacy for individuals with SMI (Franks et al., 
2009).  At a practical level, understanding the treatment moderators of self-efficacy can 
help providers of healthcare increase the efficacy of treatment interventions by 
identifying potential candidates for whom the intervention is likely to be most effective 
(Franks et al., 2009).  The present study sought to increase the current understanding of 
the correlates of healthcare self-efficacy in a population of individuals with SMI, an area 
that was previously underrepresented in the literature.  
Self-Efficacy Among Individuals with Serious Mental Illness 
 The role of self-efficacy is an important consideration in coping with chronic 
conditions.  Carpinello, Knight, Markowitz, and Pease (2000) suggested that self-efficacy 
for recovery from mental illness may be conceptualized as belief in one’s ability to 
overcome the adversities that are associated with mental illness.  Self-efficacy affects the 
amount of effort that an individual puts into coping with the disease and the tendency 
toward maintaining perseverance in coping (Raggi, Leonardi, Mantegazza, Casale, & 
Fioravanti, 2009).  Individuals with SMI may internalize the experience of stigma that is 
associated with having a mental illness (Watson, Corrigan, Larson, & Sells, 2007).  As a 
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result, they may begin to experience diminished self-efficacy and self-esteem (Watson et 
al., 2007).  However, not all individuals who have a mental illness experience a loss of 
their ability to manage their daily lives.  Some individuals respond to the damaging 
effects of stigma by increasing their determination and drive, becoming energized and 
even empowered in their attempts to maintain wellness (Watson et al., 2007).  Having a 
high sense of self-confidence in one’s own ability to act in a way that will help to control 
symptoms of psychiatric disability has been found to have health-enhancing effects in 
itself (Marks, Allegrante, & Lorig, 2005; Raggi et al., 2009).  High self-efficacy has also 
been identified as a primary mechanism associated with recovery from mental disorders 
(Anthony, 1993; Coursey, Farrell, & Zahniser, 1991; Davidson & Strauss, 1992; 
Rosenfield, 1987; Shaffer & Gambino, 1978).  
However, a percentage of individuals with SMI tend to remain relatively 
withdrawn. They may appear to be indifferent to the reality of needing to make efforts to 
take an active role in their self-care (Raggi et al., 2009).  Research has suggested that 
prior to being labeled as a person with a mental illness, people have already internalized 
stereotypes about the meaning of having a mental illness (Link, 1987; Link, Cullen, 
Struening, Shrout, Dohrenwend, 1989).  Therefore, having low self-efficacy may mediate 
the change in disease self-management behaviors, resulting in negative physical and 
mental-health outcomes (Marks et al., 2005). 
 When one faces the reality of the onset of a mental illness, the stereotypes that 
were previously formed become relevant to oneself.  Some might perceive this event as a 
stigmatizing experience and fear that rejection from their social networks and 
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communities is inevitable.  Rejection, and the thought of potential rejection, can lead to 
isolation, the possibility of job loss, eventual lowered income, and the gradual reduction 
of ability to function in the community (Watson et al., 2007).  Depending on the amount 
of perceived self-efficacy prior to the onset of a diagnosis of SMI, this negative sequence 
may be avoidable.  Therefore, it is important to determine the mechanisms that can 
impact an individual’s sense of self-efficacy to manage the daily tasks of life and his or 
her illness in order to improve outcomes.   
Self-Efficacy as an Important Variable in Recovery from Illness 
 Self-efficacy has been found to be an important variable in recovery from 
physical illnesses.  One study found that limited knowledge and self-efficacy regarding 
active self-management of one’s physical health was a primary barrier to the attempts of 
those with SMIs to engage in health-promoting behaviors (Schmutte et al., 2009).  In 
addition, results from the study indicated that despite expressed interest in learning more 
about health promotion, most of the study’s participants indicated a sense of personal 
futility and powerlessness in their ability to improve their physical health.  Furthermore, 
results from the study suggested that any effort to improve the physical wellness of 
individuals with SMI must address self-efficacy as a foundation for improving their self-
care for their health needs.  If self-efficacy is an important factor in recovery from 
physical health issues, it is logical to assume that issues of self-efficacy would be 
important in the recovery from psychiatric disability.  Individuals with SMI must feel 
able to enact the changes that are required to attend to the behaviors that will help them to 
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recover, such as asking treatment-related questions about medications, investigating other 
treatment alternatives, and actually following through with recommended treatment.  
Self-efficacy has also been found to be a significant variable in recovery from 
psychiatric disabilities. In a study that examined the relationship between participation in 
consumer-run services and recovery of social functioning in individuals diagnosed with 
SMI, researchers found that behavioral health services that focus on helping people learn 
how to cope effectively with their symptoms help consumers to become more hopeful 
and to develop a greater sense of self-efficacy, which, in turn, may increase their 
likelihood of having a positive outcome (Yanos, Primavera, & Knight, 2001).  The study 
results also suggested that there are two separate paths to recovery from mental illness. 
One suggested path may be taken by individuals who already have a high sense of self-
efficacy and who feel more confident because their symptoms are more effectively 
managed by medication (Yanos et al., 2001). These individuals may, therefore, have less 
of a need to cope in an active manner (Yanos et al., 2001).  The other path to recovery 
suggested by Yanos et al. (2001) may be taken by people who tend to cope more actively 
while experiencing more symptoms, as these individuals may feel less sure in their ability 
to manage symptoms, though they may still work more actively to manage them.  
Regardless of the pathway taken, self-efficacy plays an important role in recovery from 
mental illness.   
Based on a brief review of the literature that indicates the importance of 
individuals with SMI having a sense of their ability to effectively impact their own lives 
through the management of their mental illness, one can easily appreciate the importance 
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of assisting these individuals with enhancing their sense of self-efficacy.  Through the 
lens of social cognitive theory, individuals have vast potentiality that can be developed 
through direct and vicarious experiences. The ability to develop a strong sense of self-
efficacy is still limited, however.  The following section introduces the concept of 
empowerment and its impact on the individual with SMI.  The history of the 
empowerment movement is first discussed in order to better understand the catalyzing 
effects of this important construct.  
Empowerment 
History of Empowerment 
Empowerment is a concept that is historically rooted in the consumer movement, 
which began with the advent of the professional rehabilitation services and initiatives that 
were present in the 1970s (Chamberlin, 2009; Chamberlin, Rogers, & Ellison, 1996; 
Warner, 2009).  With this movement, the focus shifted from a medical, perhaps more 
paternal, model for treatment towards a consumer-centered focus (Chamberlin, 2009).  
Similarly, the concept of empowerment has gained the momentum of a social movement 
and has led to important changes in the way that behavioral healthcare is delivered 
(Shean, Bell, & Cameron, 2007).  The restructuring of the provision of treatment for 
individuals with SMI has been an empowering change for recipients of the treatment.  
This paradigm shift has created an environment for individuals to become actively 
involved in making decisions about their treatment (Warner, 2009).  This evolving model 
also engenders the advocacy efforts of individuals with SMI for the development of 
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accessible recovery-oriented services that will enhance the positive culture of sustained 
remission from their symptoms (Warner, 2009).  
Empowerment is an important concept in what is being labeled the recovery 
model for mental illness (Shean et al., 2007).  The model recognizes the importance of 
the subjective feelings of wellness, such as healing, hope, and empowerment.  It also puts 
emphasis on the importance of interpersonal support networks consisting of peers with 
mental illness who have been able to regain a sense of wellness and productivity in their 
lives (Warner, 2009).  Finally, the recovery model includes the significant role that these 
individuals’ service providers and other healthcare workers play in their return to more 
balanced, healthy, and productive lives (Shean et al., 2007; Warner, 2009).  Since the 
beginning of the movement, activists for change in the provision of mental-health 
services have emphasized the need to empower individuals, to collaborate with them in 
treatment decision making, and to stress that all individuals are entitled to basic human 
rights (Warner, 2009).  
The change in treatment philosophy from a medical-based model to a consumer-
centered and recovery-oriented model, has resulted in several key principles that are 
considered central to the recovery of an individual with a psychiatric disability.  First, a 
renewed understanding and desire for the eradication of stigma that has been attached to 
having a mental illness has been a central focus of the movement.  Attempts to eliminate 
the stigma of mental illness have included factors such as changing the language 
surrounding treatment and treatment-oriented care.  Second, the importance of providing 
education to the consumers of behavioral-health treatment about managing their illness in 
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order to increase understanding and empowerment has grown.  Third, the creation of 
peer-run services, mentoring, and other support mechanisms, such as drop-in centers that 
encourage wellness through advocacy, have increased (Warner, 2009).  These service 
priorities are grounded in understanding the importance of considering all individuals as 
able to recover from the debilitating effects of psychiatric disability.  
With the advent of the consumer movement and the focus on empowerment, 
clinicians who operate within traditional treatment frameworks have been educated to 
consider that their clients with SMI might be able to work, enjoy social relationships, and 
develop a support network through community involvement and inclusion (Warner, 
2009).  In addition, mental-health professionals have become aware of the active efforts 
of individuals with SMI to advocate for change in the provision of behavioral-health 
services.  Individuals recovering from a mental illness have successfully advocated to 
change legislation and program models and have started to change the perception of 
individuals with SMI.  
A growing body of data and research emphasizes the importance of empowerment 
in recovery from mental illness (Chamberlin, 2009; Warner, 2009).  It supports the notion 
that recovery and recovery-oriented care, including the development of services that are 
focused on increasing self-efficacy and reducing the experience of internalized stigma, 
are valuable in empowering individuals with SMI, thus improving their long-term 
prognostic outcome (Warner, 2009).  Furthermore, a substantial proportion of individuals 
with SMI actually fully recover from their illness.  Moreover, even more individuals are 
projected to regain a good level of social functioning (Warner, 2009). 
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In order to better understand the construct of empowerment, one must define it. 
The remainder of this section is dedicated to discussion about the development of the 
definition of empowerment, the current methods used to measure this construct, the 
importance of empowerment in recovery from mental illness, and the factors related to 
individuals’ experiences of empowerment. 
Definition of Empowerment 
 Many definitions for the term empowerment  are used to conceptualize a currently 
poorly delineated construct.  However, they all imply that empowerment includes more 
than the traditional psychological concepts of self-esteem, self-efficacy, competency, and 
internal versus external locus of control (Perkins & Zimmerman, 1995).  In general, the 
definitions are consistent in comparing empowerment to the intentional ongoing process 
centered in the local community, involving mutual respect, critical self-reflection, caring, 
and group participation.  Through this ongoing process, individuals who are found to be 
lacking an equal share of valued resources gain greater access to and control over the 
resources that are available (Cornell Empowerment Group, 1989). More simply stated, 
empowerment is the process by which people gain control over their lives, participate in 
their communities, and gain a critical understanding of their environment (Zimmerman, 
Israel, Schulz, & Checkoway, 1992).  Chamberlin (2009) suggested that the critical 
elements of empowerment include access to information, inclusion in decision making, 
assertiveness, and self-esteem.  Perhaps most interesting is the agreement that 
empowerment is both an individual and a group phenomenon, such that individuals are 
inspired by groups that are focused on these domains (Chamberlin, 2009).  Perkins and 
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Zimmerman (1995) suggested that empowerment includes the importance of interacting 
with others to achieve goals, and to gain access to resources and of the need for some 
level of critical understanding of the sociopolitical processes responsible for the 
development of treatment guidelines for individuals with psychiatric disability.  This 
definition of empowerment introduces new implications for the current model of 
psychiatric rehabilitation programs, such as allowing once disenfranchised groups, like 
individuals with SMI, to develop the programming in collaboration with mental-health 
professionals, or without the input of clinicians entirely (Chamberlin, 2009).   
Additionally, theories of empowerment also include processes and outcomes. The 
presence of processes and outcomes suggests that actions, activities, or structures may be 
considered empowering (Anthony, 1993; Chamberlin, 2009).  Thus, at the organizational 
level, these processes can be construed as collective decision making and shared 
leadership (Perkins & Zimmerman, 1995).  At the community level, processes might 
include collective action to access government and other community resources.  
Outcomes would refer to operationalizations of empowerment that allow for the study of 
the consequences of empowering processes (Perkins & Zimmerman, 1995).   
Clearly empowerment has become a critical construct of focus for understanding 
the development of individuals, organizations, and communities (Chamberlin, 2009; 
Perkins & Zimmerman, 1995; Rogers et al., 1997; Zimmerman et al., 1992).  In the last 
10 to 15 years, it has developed into a paradigm-challenging construct and is now highly 
popular in the discipline of psychology and many other fields (Kuhn, 1970; Perkins & 
Zimmerman, 1995).  The field of psychology also must investigate the relationship 
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empowerment has with other core constructs in treatment.  To address this question, one 
first needs to select the level of empowerment to be investigated.   
As previously discussed, empowerment occurs at several levels of an individual’s 
life experience.  It includes the processes by which people gain control over their lives, 
participate in their communities, and develop a critical understanding of their surrounding 
environments.  For the purposes of this study, empowerment will be measured at the level 
of the individual, not the larger societal or community level.  Specifically, the 
relationship between the provider and the consumer, a relationship representative of one 
societal structure that might be indicative of how empowered a person might feel in his or 
her daily life, will be investigated.  
Empowerment and Recovery from Psychiatric Disability 
In order to begin to understand the importance of empowerment to the consumer 
movement, one must consider that individuals who are diagnosed with a SMI may feel 
disempowered (Warner, 2009).  This sense of disempowerment may stem from 
experiences with involuntary treatment, including involuntary inpatient commitments, the 
persistent paternalistic approach that is so pervasive in current traditional outpatient and 
inpatient treatments, the ongoing societal stigma regarding individuals with mental 
illnesses, and even the stigma that individuals with psychiatric disabilities may attach to 
themselves, independent of beliefs or attitudes others may harbor towards them (Warner, 
Taylor, Powers, & Hyman, 1989).  Studies have even suggested that individuals may feel 
the need to conform to an image of incapacitation and worthlessness, or otherwise 
embody the sick role (Warner, 2009).  Of importance, this sense of disempowerment may 
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also be a manifest symptom of SMI. For example, individuals experiencing anhedonia 
may also tend to perceive they are lacking in ability to achieve at a task.  The problem 
arises when failure to attempt a task becomes a perpetual cycle, as this may result in 
individuals with SMI believing that they are ultimately dependent on their treatment 
providers or that they are unable to gain control over psychiatric disability (Warner, 
2009).  Reducing the level of stigma individuals experience and label themselves with 
may ultimately increase their sense of empowerment and eventual functioning.  Having a 
sense of empowerment is important in the recovery in individuals with schizophrenia and 
other SMI.  Empowerment challenges the pessimistic view of a diagnosis of SMI and 
other psychiatric disabilities as chronic and deteriorating (Brown et al., 2008).  
Research has been conducted to examine constructs, such as quality of life and 
self-esteem, in an effort to understand the correlates of mental illness and the factors that 
influence the efficacy of treatment (Brekke, Levin, Wolkon, Sobel, & Slade, 1993; 
Resnick, Rosenheck, & Lehman, 2004).  Interestingly, the older, more medically based 
model’s definition of recovery from mental illness remains vital to the construct of 
empowerment, in that the individual who has recovered has maintained a level of 
remission of their mental illness such that there is no trace of the illness (Resnick et al., 
2004). Indeed, if a person is no longer experiencing major symptoms of his or her mental 
illness, the consumer would understandably feel empowered and able to seek to 
reintegrate into his or her community. 
A recent definition for recovery suggests that another characterization of the 
construct encompasses the individual’s attitude toward life, or a life orientation (Resnick, 
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Fontana, Lehman, & Rosenheck, 2005; Warner, 2009).  This definition suggests the 
importance of tailoring treatment so that individuals seeking mental healthcare are able to 
experience a sense of empowerment through change in attitude toward life.  This 
treatment tailoring is thought to be the key motivating factor in a patient’s perceived and 
actual treatment outcome (Warner, 2009).  In addition, the idea that an individual is able 
to mend from the effects of the mental illness on his or her life, such as the loss of 
employment, relationships, and stable housing, suggests the likelihood that the individual 
will be able to develop a greater sense of self-efficacy.  Furthermore, tailoring treatment 
to meet the individual’s needs is, in its very essence, empowering the individual to 
achieve a level of meaning, regardless of current experience with mental illness.  Such an 
approach to treatment is likely to result in increased life satisfaction and quality of life.  
Therefore, in a person-centered model in which individuals are supported in their 
attempts to regain a level of integration with their community that meets their needs and 
creates a sense of meaning, regardless of whether or not they are still experiencing  
symptoms of a mental illness, is understandably vital to the recovery of the individual.      
Empowerment and Self-Efficacy 
The construct of self-efficacy has been linked to better treatment outcomes for 
individuals with SMI (Raggi et al., 2009).  It is also considered an important factor in 
empowering individuals. Self-efficacy, as previously defined, is one’s belief in the ability 
to enact a specific behavior (Bandura, 1977).  The presence of self-efficacy is necessary 
when dealing with a chronic illness because it can impact the effort, perseverance, 
resilience, and adherence to treatment (Raggi et al., 2009).  These factors are all 
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significant in the successful management of a chronic disease.  Therefore, having a high 
sense of confidence in one’s ability to perform the behaviors that are needed to control 
symptoms may be considered health enhancing by itself.  Low self-efficacy may mediate 
change in illness self-management behaviors and therefore worsen mental- and physical-
health outcomes (Marks et al., 2005).  When given the chance to express their own 
desires for course of treatment, one can understand that individuals will feel more control 
over their lives.  This sense of control is considered to be an important factor in the 
individual’s ability to maintain mental health and even to recover from mental illness 
(Chamberlin, 2009).  According to Cattaneo and Chapman (2010), the process of 
becoming empowered is successful only when a personally meaningful increase in power 
is obtained through a person’s own efforts, which requires the interplay of self-efficacy, 
agency, self-regulation, and self-determination.  When considering SMI, the importance 
of self-efficacy is evident.  If empowerment is, in fact, mediated by self-efficacy, and 
individuals report greater amounts of perceived self-efficacy, then greater amounts of 
empowerment should be present, as well.   
Empowerment and Adherence to Treatment 
A central theme in the treatment of individuals with SMI is the question dealing 
with the necessity and importance of empowerment in order to achieve good treatment 
outcomes (Warner, 2009).  Studies have found a correlation between an individual’s 
acceptance of mental illness and a subsequent lack of a sense of control over his or her 
life (Warner et al., 1989).  In other words, the admission of having a mental illness results 
in feelings of inability to be, or remain, in control of one’s life, especially in the presence 
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of the ongoing paternalistic model of treatment that continues to exists in the mental-
health field today (Warner et al., 1989).  A lack of sense of control in life may, plausibly, 
lead to a feeling of disempowerment.  Based on this example alone, educating individuals 
about their illness, something that most clinicians today feel is one aspect of empowering 
their clients, apparently can also have deleterious effects.  These effects include non-
adherence to treatment recommendations, such as medications, appointments for therapy, 
and follow-up with medical professionals (Warner et al., 1989).  
However, some evidence also strongly supports the importance of helping 
individuals understand their illness and its potential impact on their lives.  In a study 
conducted by Resnick et al. (2005), the concept of recovery was measured by analyzing 
data from the Patient Outcomes Research Team (PORT) client survey to identify client 
and service use variables associated with a recovery orientation.  Specifically, the 
researchers analyzed four factors: life satisfaction, hope and optimism, knowledge about 
mental illness and services, and empowerment.  Using multiple regression models, the 
study found that in each model the strongest relationship occurred between an 
individual’s recovery orientation and their lower reported severity of depressive 
symptoms (Resnick et al., 2005).  Regardless of the presence or experience of psychotic 
symptoms in individuals with schizophrenia, those who reported greater depression were 
less likely to endorse feelings of empowerment or recovery. Congruent with that finding 
was the discovery that psychotic symptoms were associated with less life satisfaction. In 
addition, knowledge about mental illness was correlated to receipt of day treatment and 
legal services.  As the authors predicted, and in line with other findings in the literature, 
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the severity of psychiatric symptoms was negatively correlated with the development of a 
recovery orientation.  Furthermore, the use of a variety of services and approaches was 
positively related with a recovery orientation (Resnick et al., 2005).  Their conclusion 
suggested that the biomedical and recovery views of mental illness, once thought to be 
mutually exclusive, actually appeared to be mutually reinforcing.  A combination of the 
two approaches seems to be most effective in the treatment of individuals with SMI.  
Therefore, if both the medical and the person-centered, recovery-oriented models of 
treatment are necessary to the recovery of an individual diagnosed with SMI, then the 
current method of mental healthcare must be reformed to include both aspects.  The 
transformation of the mental-health system suggests the importance of integrating the two 
models in order to have improved treatment outcomes for individuals diagnosed with 
serious psychiatric disabilities. 
 The conclusions drawn from Resnick et al.’s (2005) study highlight the 
importance of assisting individuals with SMI in understanding the effect of their illness 
on their ability to participate in other activities generally considered to be part of a 
recovered and empowered lifestyle.  Clinicians can use this information to guide 
treatment planning to increase consumers’ likelihood of buying into and remaining in 
treatment that may actually prevent premature termination of treatment.  To do so, 
clinicians can assist the consumer to reframe disempowering beliefs that having a mental 
illness and requiring treatment in a mental-health facility, whether outpatient or inpatient, 
prevents them from actively pursuing treatment involvement and inclusion in decision 
making. Instead, this understanding can serve to increase consumers’ sense of 
CORRELATES OF & CONTRIBUTIONS TO TREATMENT OUTCOMES              35 
 
empowerment and, therefore, improve their treatment outcomes.  By accepting the reality 
of having a mental illness, consumers who seek recovery-oriented treatment can feel 
empowered because they are able to remain in partnership with their providers to 
determine the best course of action, and thereby increase their adherence to treatment.  
Predictors and Correlates of Empowerment 
Some studies have investigated predictors of empowerment.  Rogers et al. (1997) 
were one such team who conducted statistical analyses to determine the best predictors of 
global empowerment.  They examined the respondents’ age, gender, educational status, 
ethnicity, age at first psychiatric contact, work status, total income per month, and total 
number of lifetime psychiatric hospitalizations.  After running two stepwise multiple 
regressions, only the respondents’ total monthly incomes emerged as a significant 
predictor of empowerment (Rogers et al., 1997).  Resnick et al. (2005) also correlated the 
amount of medication side effects and family’s level of understanding of the illness as 
factors that are predictive of empowerment.  Another regression used the respondents’ 
reported quality of life, community involvement, number of traditional mental-health 
services received, social support systems, and satisfaction with a self-help program.  
According to the results, the most useful predictors of empowerment were items 
measuring the quality of life, community engagement, the number of traditional mental-
health services received, and overall life satisfaction.  
Among individuals who were working, a significant relationship was found 
between the number of on-the-job hours and empowerment.  Income and earning power 
have been linked to actual power, and access to monetary resources is considered the 
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second leg of empowerment (Rogers et al., 1997).  The first leg that is considered critical 
to empowerment has already been discussed in a previous section.  Not surprisingly, the 
amount of reported self-efficacy and self-esteem, along with one’s optimism and 
perceived control over the future, is considered the most important aspect that must be 
present in order for an individual to feel empowered.  Thus, the first leg of empowerment 
can be conceptualized as a sense of self-worth and belief that one’s destiny and future life 
events are within one’s control and capability.  The third and final leg of empowerment 
includes righteous anger and community activism (Rogers et al., 1997).  In other words, 
the ability to use the experience of anger over the maltreatment of individuals with SMI 
and the lack of resources to meet the needs of this population to create change on a 
sociopolitical level is thought to comprise this final leg of empowerment.   
There appear to be many roads to empowerment, and research continues to build 
an evidence base of its predictors and its outcomes.  However, consensus is lacking on 
how to define and, ultimately, how to conceptualize this important construct.  The 
evidence presented in the literature continues to strongly suggest that individuals with 
SMI are more positively responsive to treatments that focus on the client as capable of 
being in control of his or her life.  Furthermore, a paradigm shift in the belief that SMI is 
like any other illness, one from which individuals may recover, has created a need to 
reevaluate the delivery of services from all mental-health professionals.  The therapeutic 
relationship and alliance is one logical place to start this shift.  
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Therapeutic Relationship in Mental-Health Treatment 
Interest in the therapeutic relationship among researchers and clinicians alike has 
increased over the last several decades (Horvath & Bedi, 2002).  In order to understand 
the continued research interest in this construct, several factors should be considered.  
First, a breadth of evidence suggests that different forms of psychotherapy produce 
similar benefits in patients (Stiles et al., 2004).  Thus, the majority of clinicians accept 
that a large part of what the patient finds helpful in effecting change in thought and 
behavior patterns is shared among various treatment modalities (Horvath & Bedi, 2002).  
Therefore, focus on the generic factors that are found in most psychotherapies would 
obviously include the quintessential common ground of the therapeutic relationship 
(Horvath & Bedi, 2002).  
Other reasons cited for the renewed interest in the therapeutic relationship can be 
traced to the impact of the person-centered theory developed by Rogers.  This theory 
placed the therapeutic relationship at the core of the patient’s healing process.  In 
addition, it generated a large amount of literature that explored the interpersonal aspects 
of treatment.  Other theoretical models, such as the psychodynamic and experiential 
perspectives, also focus on the relationship as the curative factor of the therapist-client 
interaction.  Despite the assertion that the relationship is the necessary and sufficient 
factor for change in therapy, a lack of empirical validity for these claims apparently has 
lessened the influence of these models of the therapeutic relationship. 
Finally, the concept and importance of the alliance has found ready use and 
acceptance in efforts to move toward an integration of the rise of theoretical eclecticism 
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that appears to have entered the field of psychology (Castonguay, 2000; Castonguay & 
Goldfried, 1994).  In other words, with attempts to move toward theoretical integration 
and reconciliation of many of the therapeutic methods that remain in conflict with one 
another, researchers of varying theoretical backgrounds have been successful in 
integrating this concept into their integrated framework for therapy (Orlinsky & Howard, 
1986).  While the definition of empowerment continues to evolve, the literature on 
working alliance, or therapeutic alliance, has reached robust findings.  This section will 
define therapeutic alliance, discuss the importance of a working relationship between the 
therapist and the consumer, and review both the therapist and the client factors related to 
an effective alliance. 
Definition of Therapeutic Alliance 
The therapeutic alliance is not synonymous with the therapeutic relationship.  
Therapeutic or working alliance has been defined as the relational, emotional, and 
collaborative cognitive connection between the client and the therapist (Johnson, Penn, 
Bauer, Meyer, & Evans, 2008; Karver, Handelsman, Fields, & Bickman, 2005).  
Specifically, it refers to the bond between the client and therapist and is recognized by the 
sense of trust the patient has in the therapist, a sense of feeling allied, and having a 
positive working relationship (Karver et al., 2005).  Bordin (1979) was the first to 
postulate that a positive therapeutic alliance has three areas of agreement between the 
client and the patient: (a) the goals of treatment, (b) the tasks to achieve these goals, and 
(c) the personal bond between the two parties. Alliance is more than simply the degree to 
which the client is involved in accomplishing specific treatment tasks.  In other words, 
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the alliance involves the role expectations of each party in the treatment (i.e., the therapist 
and the consumer), and their ability to form an attachment to one another. Bordin 
conceptualized the therapeutic alliance as the mutual agreement of the patient and 
therapist on the goals of the treatment, in which both parties agree on the tasks each is 
going to perform in the context of the relationship, and as the development of an 
attachment bond (Bordin, 1979; Summers & Barber, 2003).   
Bordin saw the therapeutic alliance as something that developed over time in the 
relationship between the patient and the therapist.  In addition, he believed that the 
alliance, and not just mere empathy or untargeted transference, was the vehicle through 
which all psychotherapies are effective.  Finally, Bordin suggested that different 
theoretical models of therapy use different aspects of the therapeutic alliance and at 
different points over the course of the treatment (Bordin, 1979; Summers & Barber, 
2003).  Based on this definition of the therapeutic alliance, the onus of the responsibility 
in the treatment is not solely reliant on the consumer to listen to and enact certain 
behavioral changes to have effective outcomes. The onus of the responsibility is also on 
the practitioner to foster a strong alliance to ensure that the most efficacious outcomes are 
attainable.  
Importance of Alliance in the Therapeutic Relationship 
Psychotherapy research has emphasized the curative aspects of the therapeutic 
relationship for many years (Marmarosh et al., 2009; Norcross, 2002).  A sizeable 
amount of literature supports assertions that the quality of the therapeutic alliance is 
predictive of the therapeutic outcome (Horvath & Greenberg, 1989; Marmarosh et al., 
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2009).  For example, outcomes research focusing on the therapeutic alliance has 
demonstrated that patients who are satisfied with their care have a greater likelihood of 
reporting greater self-confidence, being more motivated in their daily lives, practicing 
healthy behaviors, and following medical advice (Conboy et al., 2010; Greenfield, 
Kaplan, Ware, Yano, & Frank, 1988).  In addition, they report having greater confidence 
in their practitioner, thus maximizing other nonspecific healing mechanisms (Conboy et 
al., 2010).  
Evidence also suggests that the patient-therapist relationship may influence the 
patient’s health status, as the relationship serves as a primary bond and offers a form of 
social support to the patient (Conboy et al., 2010; Kaplan, Greenfield, & Ware, 1989).  
The positive impact of the patient-therapist relationship on health status is important to 
note, as high perceived or actual support has been linked to improved health outcomes in 
human and animal studies (Conboy et al., 2010).  Furthermore, patients who are less 
satisfied with their care are more likely to drop out of care, change practitioners, and 
report mistrust of their practitioner. These factors have been shown to undermine other 
aspects of the medical encounter that might be seen as adequate by the patient (Conboy et 
al., 2010).  Therefore, providers of treatment must develop an awareness of their ability 
to align with consumers, as the quality of the connection may have a significant impact 
on the consumer’s recovery.   
Overall, the therapeutic alliance plays an important role in the therapeutic process.  
Of meta-analyses and narrative reviews on the role of the therapeutic alliance, across 
diagnoses, 66 to 70% have found a significant association between treatment outcomes 
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and the working alliance that develops over time with one continuous provider (Luborsky 
& Auerbach, 1985; Orlinsky, Grawe, & Parks, 1994).  Green et al. (2008) suggested that 
individuals with SMI are particularly in need of continuity in their care because of the 
interference from their symptoms, associated memory problems, and other cognitive 
deficits related to their illness.  These illness-related interferences create difficulty for the 
patient to be an active participant in his or her treatment (Green et al., 2008).  Therefore, 
the quality of the alliance is important in establishing long-term therapist-client 
relationships.  The strength of the relationship is an important predictor of outcomes in 
individuals with SMI.   
In a study conducted by Barber, Connolly, Crits-Christoph, Gladis, and Siqueland 
(2009), the relationship among therapeutic alliance, treatment outcome, and early-in-
treatment symptomatic improvement was measured in a group of 86 patients with various 
diagnosed mental illnesses.  The results suggested that although alliance in early 
treatment could be influenced by prior symptomatic improvement, the alliance was found 
to be a significant predictor in the patients’ further improvement when controlling for 
depression (Barber et al., 2009).  The authors further stated that the role of the alliance as 
a potential causal factor in improvements remains consistent with the current theoretical 
and therapeutic role that has been suggested for alliance by previous researchers (Horvath 
& Bedi, 2002; Horvath & Greenberg, 1989; Horvath & Symonds, 1991).     
Therapeutic Alliance and Treatment Outcomes 
Qualitative and phenomenological research into the processes that positively 
influence the therapeutic relationship allows for the greater understanding of the factors 
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in therapy that enhance or reduce outcomes (Helmeke & Sprenkle, 2000).  For example, 
qualitative studies have demonstrated that the more a practitioner responds to a service 
user’s expressed practical needs, particularly in a timely manner, the greater the amount 
of trust the individual feels for the practitioner (Angell, 2012).  The consumer is thought 
to trust the practitioner because swift follow-through communicates respect and 
understanding to the service user; the practitioner acknowledges that the needs of the 
service user are important.  Therefore, the strength of the relationship increases, along 
with the likelihood that the service user will engage in treatment (Angell, 2012).  The 
converse is also true – when practitioners fail to follow through on specific tasks that they 
have promised to do, service users report a tendency to disengage because they feel that 
their service providers have let them down and that they are unimportant to their 
practitioner.   
Other qualitative studies have demonstrated that the manner in which clinicians 
communicate with their clients is integral to the development of the alliance and, 
therefore, the likelihood of positive follow-through in treatment and in outcomes (Angell, 
2012; Kreyenbuhl, Nossel, & Dixon, 2009).  Studies also show that using the consumers’ 
own language to explain the symptoms they may be experiencing enhances the 
therapeutic relationship and treatment engagement (Angell, 2012).  Furthermore, studies 
also demonstrate that by listening to consumers and allowing them to express their 
preferences for treatment, the practitioner can enhance the therapeutic relationship 
(Angell, 2012).   
CORRELATES OF & CONTRIBUTIONS TO TREATMENT OUTCOMES              43 
 
Despite the literature suggesting a strong relationship between effective working 
alliances on the treatment outcome of individuals with mental illness, few investigators 
have been able to answer the question of the predictive ability of the working alliance on 
subsequent change in symptoms or improved treatment outcomes (Barber et al., 2009).  
In fact, some studies have not been successful in demonstrating this relationship, but 
instead found that the alliance did not predict decreases in depression or substance abuse 
(DeRubeis & Feeley, 1990).  These contradictory findings regarding the effects of the 
therapeutic alliance suggest that the primary factor for the predictive capability of the 
therapeutic alliance is the patient’s perception of the relationship (Horvath & Bedi, 2002).  
Researchers have discussed the belief that nonspecific factors are important in the 
therapeutic process, particularly in outcomes-based research, which measures the 
collaboration and bond that are established between the consumer and the therapist 
(Barber et al., 2009; Castonguay, 2000; Conboy et al., 2010; Gaston, 1990).  However, 
though rarely discussed in the literature, a positive therapeutic alliance early in treatment 
might be associated with a change in a patient’s mood that has already occurred as a 
result of the therapy; thus, the patient may tend to view the therapist and the treatment 
positively, particularly if he or she has already experienced an improvement in mood 
(Barber et al., 2009).  When considering this alternative view, one must determine if the 
positive therapeutic alliance is a predictor of positive treatment outcome, of the early 
treatment improvement, or of some interaction between these two factors (Barber et al., 
2009).  Therefore, this study will seek to corroborate or provide more information about 
the predictive nature of alliance.  
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The facilitation and development of respect that grow out of developing a strong 
positive therapeutic alliance seems to be an important factor in the positive treatment 
outcomes discussed throughout the literature on this topic. Health professionals’ attitudes 
toward people diagnosed with SMI play an important role in the reduction of stigma and 
discrimination. Treating individuals with respect and dignity, and taking time to 
understand the needs and wants unique to the individual, are essential to the development 
of good therapeutic alliance (Barber et al., 2009). When the therapeutic alliance is built 
on a foundation of respect and dignity, the individual will engage more readily in the 
treatment process and feel more connected to the actual recommended treatment 
modality. Interestingly, in a study researching the distribution and association between 
specific mental illnesses and negative attitudes of mental-health professionals, individuals 
diagnosed with SMI were more likely to be perceived as being incapable of recovery and 
tended to be blamed for their mental illness (Crisp, Gelder, Rix, Meltzer, & Rowlands, 
2000).  
One can argue that an individual will be most likely to gain and maintain positive 
treatment outcomes by remaining in treatment.  For example, literature supports the 
positive outcome for homeless individuals diagnosed with SMI in the presence of a 
strong therapeutic alliance with their case management teams (Chinman, Rosenheck, & 
Lam, 2000; Solomon, Draine, & Delaney, 1995).  Additionally, in a study investigating 
whether premature termination of treatment for psychosis using cognitive behavioral 
therapy (CBT) was related to a person’s recovery style and the therapeutic alliance, 
researchers found that individuals were more likely to drop out of treatment prematurely 
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if they disagreed on the goals and tasks of the treatment, as assessed by the Working 
Alliance Inventory (WAI) scale (Startup, Wilding, & Startup, 2006).  Interestingly, those 
who dropped out of the treatment did not differ significantly in the Bond subscale of the 
WAI from those who remained in treatment.  McGlashan (1987) argued that the goal of 
treatment should, therefore, not focus on altering the individual’s personal recovery style, 
but to match treatment to the person’s presenting style.  This suggests the importance of 
alliance in the relationship, perhaps the greatest predictor of success in treatment.  
The importance of the therapeutic alliance continues to be reviewed in the 
provision of psychotherapeutic treatments because, as previously noted, much of the 
treatment success relies on this aspect of care.  Perhaps a corollary to the therapeutic 
alliance is the clinician’s willingness to include the consumer in the process of treatment 
planning.  The following section will review the current literature on participatory 
decision making.  In particular, this section will discuss the definition of participatory 
decision making, the factors that are believed to contribute to this style of interaction, and 
the contribution this form of inclusion has on treatment outcomes.  
Participatory Decision-Making 
During the past several decades, the idea that patients should be involved in the 
decision-making process of treatment has arisen from advocacy efforts of the very 
consumers who are receiving the treatment.  Involving individuals in treatment decision 
making is also garnering greater interest with the increasing pressure from insurance 
companies and professionals in the field to use evidenced-based treatment in treatment 
planning (Elwyn et al., 2001; Warner, 2009).  Research evidence demonstrates that the 
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desires and choices of clients who have not been informed of choices in treatment change 
once they have been educated on both the benefits and the potential harms of different 
treatment options (Elwyn et al., 2001; Wolf, Nasser, Wolf, & Schorling, 1996). 
Furthermore, if the clinician involved in the relaying of this information is skilled and 
sensitive to the individual needs and concerns of the patient, this change in choices is 
more likely to occur (Wolf et al., 1996).  In reality, a patient’s right to autonomy and self-
determination will influence the clinician’s proposed treatment plan even after the patient 
has been informed of his or her options. Through the model of participatory decision 
making (PDM), understanding this reality is critical to deciding how the clinician will 
collaborate with the patient (Elwyn et al., 2001).  The need to honor patient’s right to 
autonomy suggests to clinicians in the field the importance of understanding how 
inclusion in decision making can best be employed in order to increase the likelihood for 
successful treatment.  The following presents a definition for inclusion in treatment 
decision making, also known as participatory or shared decision making.  
Definition of Participatory Decision Making (PDM) 
PDM between a practitioner and the consumer of the services refers to the amount 
of communication that is fostered by the clinician with the patient regarding the direction 
of the treatment (Street, Makoul, Arora, & Epstein, 2009).  It denotes an interactive 
process during which clients and practitioners collaborate in order to make healthcare 
decisions (Adams & Drake, 2006).  This collaboration assumes that both parties have 
important information to contribute to the treatment process.  The practitioners hold 
information about the current and correct diagnosis, course of illness, treatment options, 
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moderating factors, and evidence-based information regarding and side effects of the 
different treatments (Adams & Drake, 2006).  Likewise, the clients are the experts on 
their own values, treatment preferences, and goals for treatment (Charles, Gafni, & 
Whelan, 1997).  
A crucial aspect of PDM is the presence of the patient’s right to choose; the 
consumer makes decisions regarding the roles and the level of participation he or she will 
assume (Adams & Drake, 2006).  If viewing choice as a spectrum with two opposing 
ends, then clients may fall along the continuum at different points.  For instance, at one 
end, clients may adopt a dominant role in which they make the decisions and the 
practitioner merely provides the information on the risks and benefits.  At the other end 
of the spectrum, the clients may opt to defer decision-making power and abrogate 
control, giving sole responsibility to the practitioner (Elwyn & Edwards, 2001).  
However, many clients choose a more balanced role in decision making.  They prefer to 
engage in a dialogue with their practitioner about the treatment issue and reach a 
consensual agreement on treatment approach (Adams & Drake, 2006).  
PDM, in general, involves a shared responsibility for developing and meeting 
treatment goals.  A consumer with a possibly longer term illness, such as SMI, must learn 
to accept the need to take responsibility for his or her own care on a daily basis.  For 
example, the consumer must remember to take medications not only for the mental 
illness, but also for any other medical illnesses for which medications may be prescribed.  
This part of gaining and/or maintaining wellness is essential.  Given this example, 
however, both the practitioner and the client must keep in mind that the client’s 
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perspective, capacity to make changes, and role will change over time (Adams & Drake, 
2006).  As has been outlined in the stages of change theory, a process of acceptance and 
responsibility is usually present in an individual who learns to manage a chronic or longer 
term illness (Prochaska, DiClemente, & Norcross, 1992).  However, according to the 
current medical models of treatment for chronic and long-term illnesses, the clinician 
continues to be the client’s guide in making choices about living with the condition and 
making an optimal adaptation (Adams & Drake, 2006; Auerbach, 2001).  By 
participating in making healthcare decisions, or sharing the decision-making tasks, the 
client will most likely increase his or her engagement in treatment, and his or her 
“knowledge, confidence, skills, and commitment to making an optimal adjustment” 
(Adams & Drake, 2006, p. 88).  
Factors Related to a PDM Style 
Therapist variables.  Research suggests that practitioners who present options to 
consumers, who discuss thoroughly the pros and cons of the options, who elicit the 
consumers’ preferences, and who establish mutually agreed-upon goals are said to have 
employed a PDM style (Kaplan, Greenfield, Gandek, Rogers, & Ware, 1996).  These 
treatment providers are thought to have greater success in their alliance with their 
patients, which may result in better treatment outcomes when compared to physicians 
who have a more controlling decision-making style (Kaplan et al., 1996). 
Research also suggests that practitioners’ sense of autonomy is an important key 
in the use of an inclusive decision-making style (Adams & Drake, 2006; Kaplan et al., 
1996).  Kaplan et al. (1996) determined that physicians who reported being satisfied with 
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the amount of personal autonomy they experienced in their jobs and who reported 
practicing independently were rated as more participatory than physicians who were not 
satisfied.  Therefore, if personal autonomy is related to a more inclusive treatment style, 
then physicians’ perceptions of more control in their practice are more likely to engage in 
a PDM approach to treatment.  Furthermore, practice situations that encourage a sense of 
autonomy may enhance the quality of interpersonal care that the physician is providing 
(Kaplan et al., 1996).  Practice volume may have a large impact on the ability of 
physicians to interact in an inclusive treatment style because physicians in busy practices 
may be unable to spend the time that is necessary to develop rapport and allow for the 
free discussion of questions about treatment, treatment options, and preferences for 
treatment approach (Kaplan et al., 1996).  Therefore, the quality of interpersonal care 
may be underestimated as a consequence of practice volume (Kaplan et al., 1996).   
In addition to perception of autonomy, a physician’s race had an impact on 
patients’ perceptions of inclusion.  For example, in the Kaplan et al. (1996) study, 
nonwhite physicians were reported to be less participatory than their white counterparts 
after adjusting for the greater practice volume of nonwhite physicians.  Kaplan et al. 
(1996) did not publish their thoughts about the reason for this apparent discrepancy, 
though they did recommend that future efforts should explore cultural differences that 
may have impacted the physician’s interpersonal style and technical care.  However, 
underlying multicultural and diversity issues may have an impact on the experience of the 
patient, or the practitioner may also practice with a more exclusionary style. 
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Consumer variables.  Research on the interaction between medical doctors and 
their patients has demonstrated that consumers who feel they have an active part in their 
treatment decision making are more likely to follow through on those decisions than 
those who do not have an active role (Kaplan et al., 1996).  This apparent relationship 
between treatment engagement and inclusion in treatment decision making has particular 
relevance for practitioners who treat individuals with a chronic or longer term illness, as 
the majority of the treatment plan must be carried out by the consumers (Kaplan et al., 
1996).  In order for maximum treatment effectiveness, the consumer needs to commit to 
working daily on his or her treatment plan and recommendations.  In addition, patients 
who ask more questions of their doctors, who elicit treatment options, and who express 
their treatment preferences during their visits with their physicians have measurably 
better health outcomes than those patients who are more passive in their interaction style 
(Kaplan et al., 1996).  Although the previously cited literature focused on the 
communication style of physicians in the medical realm of practice, and not on therapists 
or behavioral-health professionals, the information is at least relevant to the 
understanding of the importance of inclusion in treatment planning.  There is a dearth of 
literature that focuses specifically on the construct of PDM in the behavioral-health 
profession.  Therefore, results from this study will increase the current literature that 
exists about this important concept.   
PDM Style and Treatment Outcomes  
Physicians are encouraged to adopt a treatment style that involves the consumer in 
decision making because the evidence from the medical literature suggests that this 
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approach can help a patient gain control of a chronic disease and experience greater 
functional outcomes (Shields, Franks, Fiscella, Meldrum, & Epstein, 2005).  However, to 
date the evidence for these outcomes is mixed (Adams & Drake, 2006).  Literature, 
though sparse, supports both the self-reported improvement of functioning in individuals 
and the lack of improvement in outcomes related to illness management when a treating 
physician uses a PDM style.  Improvements in functioning are generally related to the 
reported reduction in psychological distress that has become associated with the 
practitioner’s provision of information and adoption of a more client-centered 
communication style (Kiesler & Auerbach, 2003).  Clients who are under the care of a 
practitioner who engages in a PDM style reported more satisfaction in their care than a 
control group whose practitioners did not utilize a PDM style (Adams & Drake, 2006).  
Although perceived PDM is associated with positive outcomes, the results appear to be 
related solely to the clients’ perceptions (Greenfield et al., 1985).  Rogers, Vergare, 
Baron, & Salzer (2007) have suggested that providers’ anticipation of clients’ treatment 
“failure” may prevent the development of a sense of ability to take risks and pursue 
meaningful goals.  The positive impact of a PDM style suggests the need for further 
understanding of ways providers can engage individuals in their treatment, including 
getting a better understanding of what the individuals’ goals are and communicating 
clearly with the individuals through a process of informed consent and inclusion in the 
process (Epstein, Alper, & Quill, 2004).  
Studies that have been conducted on patients’ perceptions of their physicians’ 
efforts to include them in the decision-making process have reported greater patient 
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satisfaction, better self-management of the illness, increased likelihood that the patient 
will request information about alternative or complementary treatments, decreased need 
for hospitalization, and better health-related quality of life (Heisler, Bouknight, Hayward, 
Smith, & Kerr, 2002; Kaplan et al., 1996; Sleath, Callahan, Devellis, & Beard, 2008).  
Additionally, communication styles appear to be related to PDM style.  In a study that 
measured cancer survivors’ perceptions of their treating physicians’ tendencies to utilize 
a PDM style, researchers found that physicians’ PDM style was significantly related to 
proximal communication about the treatments and illness, intermediate cognitive 
outcomes, and distal health outcomes.  Furthermore, survivors were more likely to feel 
and be more confident in actively participating in the treatment decision-making (Neeraj, 
Weaver, Clayman, Oakley-Girvan, & Potosky, 2009).  In the same study demonstrated 
that use of a more inclusive style of decision making by the physician may be associated 
with better mental health by both increasing survivors’ perceptions of personal control 
and enhancing the level of trust between the physician and the patient (Neeraj et al., 
2009).  Therefore, although a gap remains in the literature demonstrating the connection 
between PDM and empowerment, as suggested by Street et al. (2009) and results from 
the previously mentioned study, physicians who involve their patients in the process of 
treatment are more likely to increase and enhance their patients’ sense of self-efficacy for 
interacting with their physicians.  
PDM Style and Treatment Engagement 
The medical field has been studying the benefits of adopting and using an 
inclusive decision-making style for a longer duration and in more depth than has the 
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behavioral-health field.  Previously unchecked power differentials between physician and 
patient resulted in a culture of belief that the patient was to be seen as a passive recipient 
of decisions that were made by the physician (Auerbach, 2001).  However, with the rise 
of awareness and dissemination of recovery-oriented approaches to treatment, the 
paternalistic approach has been challenged on both the ground level and by policy-
makers, calling for increased inclusion in treatment decision making by the patient 
(Auerbach, 2001; see New Freedom Commission on Mental Health, 2003a/2003b).  
Since these challenges, both medical professionals and lay people have argued that 
patients should be fully informed of important medical information and be active 
participants in their care (Auerbach, 2001).  This change was made in order to correct, or 
balance, the misappropriated power differential.  Although the behavioral-health field has 
been slow to include this important concept into the provision of care and delivery of 
services, the call to action since the development of the Recovery to Practice Initiatives 
and Guidelines has brought into light the value and validity of this approach in delivery 
of treatment services.  
Using an inclusive approach to treatment planning implies care and concern about 
the patient’s needs, desires, and wishes.  It also implies the active engagement of patients 
by treating clinicians in all areas of decision making and involves, at a minimum, a 
clinician and the patient, as well as other members of the patient’s family and/or support 
network.  Shared decision making requires both parties in the relationship to share 
information, where the clinician provides information about the options and the potential 
risks and benefits and the patient makes an informed decision of the course of treatment 
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(Barry & Edgman-Levitan, 2012).  Research results investigating the effectiveness of 
increasing treatment engagement of individuals with SMI are mixed.  In a meta-analysis 
conducted by Cochrane Systems reviewing the primary and secondary effects of 
inclusion in decision making between inpatient individuals diagnosed with schizophrenia 
and individuals in primary care newly diagnosed with depression, no evidence of effect 
on clinical outcomes or hospital readmission rates was found in either population.  
Furthermore, the intervention did not increase patients’ compliance with their treatment 
plans.  However, some evidence suggested that interventions that were introduced to 
increase shared decision making did positively affect physician facilitation of patient 
involvement in decision making and did not require longer consultation times (Duncan, 
Best, & Hagen, 2010).  The consensus of the researcher was that no firm conclusions 
could be drawn from the two sample populations that were used in the research.  
However, of note, the results indicate the need for further research into the potential 
benefactors of satisfaction with received treatment and engagement in the treatment.   
In another meta-analysis conducted by the group, two studies of relatively good 
quality were identified and then examined for the impact that a clinician’s use of an 
inclusive decision-making style had on treatment outcome satisfaction, health outcomes, 
and readmission rates (Duncan et al., 2010).  In one of the two studies, the intervention 
had a short-term positive effect on satisfaction with the treatment.  In the other study, 
consumer involvement in the decision-making process was increased when the physician 
led the intervention.  Of note, no effects were obtained on the clinical and health service 
outcomes in either of the studies.  The lack of sufficient evidence regarding the use of an 
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inclusive decision-making style suggests that further research is needed to determine the 
impact that shared decision making has on engagement in treatment.   
Self-Efficacy, Empowerment, Alliance, and PDM Style in Individuals with SMI 
 Evidence supports the importance of having a PDM style for treatment success in 
the provision of mental-health services.  However, both the clinician and the consumer of 
services contribute to the development of this important style of communication.  In order 
to best set the foundation for treatment success in individuals with SMI, issues of self-
efficacy, consumer empowerment, development of a strong therapeutic alliance, and 
inclusion in treatment decision making are several necessary components that must be 
considered.  Although literature examines these constructs individually, or with other 
aspects of treatment outcomes, no studies have evaluated the interaction of these four 
variables on perceived treatment outcome for an individual with SMI.   
In lieu of the mandate to transform the delivery of behavioral-health services in 
the United States, the constructs in this study represent an attempt to better understand 
the constructs and the processes that yield effective treatment outcomes in the presence of 
a recovery-oriented approach to treatment.  Therefore, this study seeks to determine the 
relationships among and the relative contributions of the constructs of empowerment, 
therapeutic alliance, self-efficacy, and PDM style on the treatment outcomes in 
individuals diagnosed with SMI.  In addition, this study seeks to better understand how 
these three constructs interact with and influence one another (see Figure 1)
2
.  There is a 
                                                 
2     Anticipated relationships are that overall global empowerment and the working alliance will predict perceived efficacy in patients’ 
interactions with their physicians, a more specific variable. Additional expected relationships are that overall empowerment (ES), the 
working alliance and perceived efficacy in interactions with physicians will predict inclusion in treatment decision making. All of 
these constructs will be predictive of perceived treatment outcomes operationalized as satisfaction with treatment. 
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Figure 1.  Conceptual model of hypotheses 1, 2, and 3.  ES = Empowerment Scale; WAI 
= Working Alliance Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy 
in Patient-Physician Interaction Scale; PDMS sum = Participatory Decision-Making 
Scale (sum score); MHSIP sum = Mental Health Statistics Improvement Program (sum 
score). 
 
 
 
dearth in the literature to explain the relationship between empowerment and PDM, 
empowerment and satisfaction with received treatment, and treatment specific self-
efficacy and empowerment.  Results from this study will provide important information 
that will help to guide program development and training for clinicians providing services 
to the individuals and to guide future research on effecting positive treatment outcomes 
for individuals with SMI.  Furthermore, the information specifically related to the impact 
of consumer rated perceptions of empowerment will serve to increase the current 
literature about this dynamic construct.  Finally, anticipated results will assist those 
providing behavioral-health services to individuals with SMI to better conceptualize the 
factors that are more likely to result in consumer follow-through of treatment planning, 
ES 
WAI 
PEPPI PDMS MHSIP 
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particularly in relation to the required transformation that is occurring in the delivery of 
mental-health services. 
Classes of Predictors 
These correlates of treatment outcomes can be categorized into several classes of 
predictors that can be conceptualized as within or internally based, like a trait versus state 
characteristic, and externally based or process-related variables. For the purposes of this 
study, the construct of empowerment should be considered a trait-specific characteristic, 
where the individuals’ sense of global empowerment is measured by the Empowerment 
Scale.  Additionally, the construct of self-efficacy should be considered to be a state-
specific characteristic, in that the individual’s sense of self-efficacy is context dependent 
on his or her perception of the effectiveness of interactions with physicians. Self-efficacy 
is measured by the Perceived Efficacy in Patient-Physician Interaction Scale. The 
construct of PDM should be considered an external variable that is reliant on the 
physician/clinician’s style of more or less inclusion afforded to the client in treatment 
decision making.  PDM is measured by the Participatory Decision-Making Scale. Finally, 
the construct of therapeutic alliance should also be considered to be a process-related 
external dependent variable, such that the therapeutic alliance requires by definition the 
bond that develops between the therapist/clinician/physician and the individual.  The 
therapeutic alliance is measured by the Working Alliance Inventory-Client Version-Short 
Form. 
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Chapter 3: Hypotheses 
Research Question 1 
What is the relative contribution of the therapeutic alliance and global 
empowerment to patients’ perceived self-efficacy in their interactions with their 
physicians?  Does the working alliance, as measured by the Working Alliance Inventory- 
Client Version, Short Form (WAI-C-S), and perceived global empowerment, as measured 
by the Empowerment Scale (ES), predict patients’ perceived self-efficacy in their 
interactions with their psychiatrists, as measured by the Perceived Efficacy in Patient-
Physician Interactions Scale (PEPPI)? 
Alternative Hypothesis 1   
High levels of self-reported working alliance and global empowerment are 
positively correlated to greater reports of perceived self-efficacy in patients’ interactions 
with their psychiatrists.  
Null Hypothesis 1 
High levels of working alliance and global empowerment will not be significantly 
related to high levels of reported perceived self-efficacy in interactions with psychiatrists.  
Justification for Hypothesis 1 
The importance of the working alliance in therapeutic interactions has been 
repeatedly documented as an important predictor in therapeutic outcome (Barber et al., 
2009; Green et al., 2008; Pos, Greenberg, & Warwar, 2009).  For individuals with SMI, 
this relationship can be difficult to secure at times and can take longer to develop (Barber 
et al., 2009).  The therapeutic alliance has been linked to greater reports of self-efficacy 
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in individuals diagnosed with SMI (Rogers et al., 1997).  Thus, individuals’ reports of 
greater therapeutic alliance should result in higher endorsement of self-efficacy when 
interacting with their physicians.  
Summary of Relevant Work 
The relevancy of the construct of therapeutic alliance in the ability of an 
individual with SMI to recover and lead a meaningful and productive life  has been a 
large focus of the treatment of mental illness (Horvath & Bedi, 2002; Horvath & 
Greenberg, 1989; Horvath & Symonds, 1991; Pos et al., 2009).  When therapy begins, 
clients respond globally to the experience by their desire to be listened to and to engage 
in the therapeutic process.  Without these needs being sufficiently met in a timely 
manner, there is a risk of early termination (Horvath & Bedi, 2002).  In a study conducted 
by Barber et al. (2009), results suggested that although alliance in early treatment could 
be influenced by prior symptomatic improvement, the alliance was found to be a 
significant predictor in patients’ further improvement when controlling for other potential 
comorbidities (Barber et al., 2009).  Therefore, for individuals with SMI, the perceived 
therapeutic alliance is an important construct to measure in order to achieve the goal of 
recovery from psychiatric disability.  
Research Question 2 
To what extent does perceived self-efficacy in interactions with psychiatrists, 
perceived global empowerment, and perceived therapeutic relationship predict patients’ 
perceptions of inclusion in treatment decision making?  How does individuals’ perceived 
self-efficacy in interactions with their psychiatrists, as measured by the Perceived 
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Efficacy in Patient-Physician Interactions Scale (PEPPI), perceived global empowerment, 
as measured by the Empowerment Scale (ES), and perceived therapeutic alliance, as 
measured by the Working Alliance Inventory-Client Version, Short Form (WAI-C-S), 
impact on a patients’ perceptions of inclusion in treatment decision making, as measured 
by the Participatory Decision-Making Scale (PDMS)? 
Alternative hypothesis 2 
Individuals who report higher levels of perceived self-efficacy in interactions with 
their psychiatrists, higher sense of global empowerment, and greater alliance with their 
clinicians will report greater sense of inclusion in treatment decision making. Individuals 
who report low levels of perceived self-efficacy when interacting with their psychiatrists, 
low global empowerment, and minimal alliance with their clinicians will report not 
feeling included in making treatment decisions. 
Null Hypothesis 2 
The level of perceived self-efficacy and therapeutic alliance individuals 
experience with their psychiatrists and the level of global empowerment that individuals 
experience in their daily lives will not be correlated with their sense of inclusion in 
treatment decision making. 
Justification for Hypothesis 2 
Physicians are encouraged to adopt a treatment style that involves the individual 
in the decision-making process because of the evidence in early literature that suggests 
that this approach can help a patient gain control of a chronic disease and experience 
greater functional outcomes (Shields et al., 2005).  Because of the real concern of rising 
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healthcare costs for these particularly vulnerable individuals, determining any factors that 
may mitigate the use of expensive crisis services is important.  
Summary of Relevant Work 
Self-efficacy has been linked to better treatment outcomes for individuals with 
SMI (Raggi et al., 2009).  It is also considered an important factor in empowering 
individuals.  The presence of self-efficacy is very essential when dealing with a chronic 
illness because it can impact the amount of effort, perseverance, resilience, and adherence 
to treatment (Raggi et al., 2009).  These factors are all key in the successful management 
of a chronic disease.  Having a high sense of self-confidence in one’s own ability to act in 
a way that will help to control symptoms of mental illness has been found to have health-
enhancing effects in itself (Marks et al., 2005; Raggi et al., 2009).  Conversely, having 
low self-efficacy may mediate the change in disease self-management behaviors, 
resulting in negative physical and mental-health outcomes (Marks et al., 2005).  When 
considering SMI, often a chronic disease, one can appreciate the importance of self-
efficacy to outcomes is evident.   
Research Question 3 
What is the relative contribution of the therapeutic alliance, perception of global 
empowerment, perceived self-efficacy in interactions with physicians, and inclusion in 
treatment decision making to individuals’ perceived treatment outcomes?  How does the 
therapeutic alliance, as measured by the Working Alliance Inventory-Client Version, 
Short Form (WAI-C-S), global empowerment, as measured by the Empowerment Scale 
(ES), self-efficacy in interactions with physicians, as measured by the Perceive Efficacy 
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in Patient-Physician Interactions Scale (PEPPI), and perception of inclusion in treatment 
decision making, as measured by the Participatory Decision Making Scale (PDMS) 
impact individuals’ perceived treatment outcomes, as measured by the Mental Health 
Statistics Improvement Program Consumer Survey (MHSIP)? 
Alternate Hypothesis 3   
Perception of positive treatment outcomes in individuals diagnosed with SMI is 
predicted by the therapeutic relationship, sense of personal empowerment, sense of 
perceived efficacy in their interactions, and the physician’s inclusive style in treatment 
decision making.  
Null Hypothesis 3 
The perceptions of individuals with SMI regarding inclusion in treatment decision 
making, the therapeutic relationship, personal empowerment, and sense of efficacy in 
interacting with their clinicians is not related to their self-reported treatment outcomes.  
Justification for Hypothesis 3 
Accumulating data collected from empirical studies show that patients of 
physicians who approach patient care by encouraging them to participate more actively in 
treatment decision making have more favorable health outcomes (Greenfield, Kaplan, & 
Ware, 1985; Kaplan, Greenfield, & Ware, 1989).  Furthermore, the quality of the 
therapeutic alliance and the presence of personal empowerment are important factors in 
an individual’s recovery from SMI (Barber et al., 2009; Resnick et al., 2005).  
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Summary of Relevant Work 
Evidence in research demonstrates that the desires of patients who have not been 
informed of choices in treatment alter once they have been informed of both the benefits 
and the potential harms of different treatment options (Elwyn et al., 2001; Wolf et al., 
1996).  Furthermore, if the clinician involved in the relaying of this information is skilled 
and sensitive to the individual needs and concerns of the patient, this change in desires is 
more likely to occur (Wolf et al., 1996).  Elwyn et al. (2001) suggested that, “any attempt 
to measure involvement in decision-making should therefore consider to what degree (if 
any) a health professional portrays choices and invites patients to participate in the 
decisions, along with other processes that may be associated” (p. 6).  Understanding that 
patients’ rights to autonomy and self-determination can usurp the professional clinician’s 
point of view even after they have been informed of their options is critical to deciding 
how the treatment will progress (Elwyn et al., 2001).  
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Chapter 4: Methods 
Overview 
This study sought to determine the relative contribution of empowerment, as 
defined previously, and working alliance on an individual’s reported perceived efficacy 
in patient-physician interactions.  Secondly, this study also sought to determine the 
importance of the perceived efficacy that individuals experience in their interactions with 
their physicians.  Finally, this study sought to determine the relationships between the 
previously mentioned variables on perceived satisfaction of treatment received.  The 
constructs used in this research included empowerment, working/therapeutic alliance, 
treatment outcomes, participatory decision making (PDM), and self-efficacy.  This study 
used the empowerment scale (ES), Working Alliance Inventory-Client Veresion, Short 
Form (WAI-C-S), the Mental Health Statistics Improvement Program Consumer Survey 
(MHSIP) scale, the Participatory Decision-Making Scale (PDMS), and the Perceived 
Efficacy in Patient-Physician Interactions Scale (PEPPI) to measure these constructs.  
Design and Design Justification 
 This study used an existing data set to assess the nature of the relationships 
between global empowerment and working alliance on individuals’ perceived efficacy in 
their interactions with their physicians.  This study also used the existing data set to 
determine the relationship between perceived efficacy and their treatment outcomes.   
Data Set 
This data set was part of a large longitudinal study consisting of 396 individuals 
who were served at community mental-health centers throughout the city of Philadelphia.  
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As a result of the large size of the data set, this study was able to answer important 
questions about how the constructs of empowerment, working alliance, and self-efficacy 
are correlated with the individuals’ sense of inclusion in treatment decision making and 
their perceived treatment outcomes.  Furthermore, using an existing data set minimized 
the risk of loss of confidentiality and anonymity, as this data set consisted of information 
that was deidentified.   
Participants 
 Three hundred and ninety-six (396) participants were recruited at three area 
community mental-health agencies in Philadelphia, Pennsylvania, for the original study.  
These agencies included Community Organization for Mental Health and Retardation 
(COMHAR), Community Council, and Hall Mercer, and agreed to work with the 
research team from the University of Pennsylvania.  All 396 participants completed the 
baseline interviews.  Data were collected from an approximately equal number of 
participants at each of the participating sites. In all, 247 participants (62%) were Black, 
and 149 participants (38%) were White, according to administrative records provided by 
each agency.  The data on racial background obtained by Salzer, Brusilovsky, Rothbard, 
and Hadley (2007), client self-reported information, were different from agency-based 
records in that 199 participants reported they were Black, and 123 participants said they 
were White.   
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Inclusion and Exclusion Criteria 
Inclusion Criteria for Original Data Set 
The criteria for eligibility, as determined by Salzer et al. (2007), included the 
following: (a) individuals with a primary Axis I diagnosis of schizophrenia, a 
schizophrenia-spectrum disorder, or major depression; (b) individuals who were 
categorized as White or Black in the records of participating agencies; (c) individuals 
over the age of 18 years; and (d) individuals who were receiving prescriptions for 
psychiatric medication from the mental-health agency.    
Exclusion Criteria for Original Data Set 
Individuals who were unable to read or speak English were excluded from 
participating in the original collection of the data.  In addition, individuals who could not 
be reached by phone call were excluded from participating in the original data collection.  
Screening Procedures for Original Data Set 
Screening procedures were used to verify the presence of an Axis I diagnosis of 
schizophrenia or major depression.  The screening process entailed having the participant 
sign a release of information that would allow the research team to contact an agency 
staff member, identified by the participant, to confirm the participant’s diagnosis 
according to patient records. 
Recruitment for Original Data Set 
The research staff involved in the original recruitment procedures informed the 
staff at the participating agencies of the opportunity for consumers with SMI to 
participate in a research study.  They then directed staff to approach their consumers to 
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inform them of the study and gain their consent for research staff to contact them.  A 
consent to contact form was completed and then returned to the research staff.  All 
subjects who consented to speak to the research staff were contacted and informed about 
the study.  If they agreed to participate, they then provided written consent, and 
completed a baseline interview, and follow-up interviews.  
Plan for Informed Consent Procedures 
This study used a preexisting archival data set.  Therefore, this study did not 
require further informed consent procedures.  
Measures 
Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI; Maly et al., 
1998) 
The PEPPI was developed to measure subjects’ sense of perceived self-efficacy in 
their interactions with their physicians.  The scale assesses patients’ subjective sense of 
confidence when interacting with their physicians (Maly et al., 1998).  The scale is 
comprised of 10 questions that were developed to measure patients’ confidence in their 
ability to elicit and comprehend the information they receive, as well as to communicate 
information to their physicians.  It was also designed to measure patients’ confidence in 
their ability to get their physicians to address and act on their reported medical concerns.  
The items that are included in the scale are based on issues that older adult patients 
brought to light about their interactions with their physicians in open-ended questioning 
during a study of adherence with geriatric assessment recommendations, as well as the 
authors’ observations of or participation in encounters between patients and their 
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physicians (Maly et al., 1998).  Each item of the PEPPI begins with the basic leading 
question of, “How confident are you in your ability to…”  Subjects respond to each 
question on a Likert scale of 1 to 5, with 1 representing “not at all confident” and 5 
representing “very confident” (Maly et al., 1998).  Thus, the range of possible scores for 
the 10-item PEPPI scale is 10 to 50, with 50 representing the highest possible amount of 
patient-perceived self-efficacy.  The full scale takes approximately 3 minutes to 
administer, with no reported comprehension difficulties from the subjects (Maly et al., 
1998).  The internal reliability coefficients (Cronbach's alpha) for the full 10-item PEPPI 
scale are calculated to be 0.90 and 0.91.  Thus, the PEPPI demonstrates high convergent 
and discriminant construct validity (Maly et al., 1998).  
Empowerment Scale (ES; Rogers et al., 1997) 
This scale was developed by Rogers et al. (1997) to measure the amount of global 
empowerment that mental-health consumers experienced when interacting with their 
physicians during regular medication appointments.  It is being used in this study to 
determine the amount of perceived global efficacy or empowerment that a participant was 
experiencing at the time of data collection.  It consists of a 28-item, self-report survey.  
The scale yields a total empowerment scale, as well as five subscale scores derived from 
a factor analysis (Rogers et al., 1997).  The subscales include self-efficacy-self-esteem, 
power-powerlessness, community activism, righteous anger, and optimism-control over 
the future (Brown et al., 2008).  In two studies of reliability using Cronbach’s alpha, the 
full scale yielded high internal consistency of .85 and .86; the reliability coefficients for 
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internal consistency for five subscales ranged from .51 to .91 (Rogers et al., 1997; Wowra 
& McCarter, 1999).  
The authors developed a survey with the assistance of a consumer research 
advisory board. At the beginning of the research project, 10 individuals were selected to 
be a part of a consumer research advisory board (Rogers et al., 1997). These individuals 
were leaders in the consumer/survivor movement and were able to represent the various 
factions of that movement.  The board then held several meetings to design and plan the 
research study, as part of the participatory action research that is encouraged by consumer 
activist groups (Rogers et al., 1997).  During the meetings, the board outlined 15 
attributes of empowerment, based on the definition of psychological empowerment 
previously reviewed (Rogers et al., 1997).  After arriving at a consensus about the 
definition and its many dimensions, the board determined the items for the scale.  They 
were modeled after the Rotter Internal-External Locus of Control instrument, the Self-
Efficacy Scale, and the Rosenberg Self-Esteem Scale (Rogers et al., 1997).  
Working Alliance Inventory – Client Version, Short Form (WAI-C-S; Horvath & 
Greenberg, 1989) 
The WAI-C-S was used in this study to measure the perceived amount of 
therapeutic alliance that the patient experienced in the interaction.  This tool was 
developed by Horvath and Greenberg (1989).  This 36-item scale consists of a 7-point 
Likert scale, anchors, and three subscales.  These subscales include the degree to which 
the client and therapist bond or become attached, the degree to which the client and 
therapist collaborate on specific therapeutic activities or tasks, and the degree to which 
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the client and therapist agree on the global objectives or goals of the therapy (Horvath & 
Greenberg, 1989). Cronbach’s alpha for the total score is .92, and the subscales all have 
reliability estimates that are greater than .74, suggesting adequate reliability (Horvath & 
Greenberg, 1989).  In order to reduce the possibility of a social desirability bias, the 
participants were informed that their responses would not be shared with their respective 
therapists, but would be available only to the research team (see also Salzer et al., 2007).  
Mental Health Statistics Improvement Program Adult Consumer Survey (MHSIP; 
Eisen et al., 2001) 
The MHSIP Consumer Survey was developed with input from stakeholders 
involved and connected with the Center for Mental Health Services (Eisen et al., 2001).  
The purpose of the measure was to evaluate the performance of a mental-health system in 
the domains of accessibility, quality and appropriateness of services, and treatment 
outcomes from the consumers’ perspective (Jerrell, 2006).  Satisfaction items were also 
included in the scale.  After the psychometric properties were analyzed, structures of 
three factors were confirmed using 16 items.  These include access to care, quality and 
appropriateness of services, and outcomes (Jerrell, 2006).  Satisfaction questions were 
widely used, making the scale a 21-item survey (Jerrell, 2006). This scale is based on a 
Likert scale, where 1 indicates “Strongly Agree” and 5 indicates “Strongly Disagree.”  
For all of the subscales, the Cronbach’s alpha coefficients were in the good range, from 
0.73 to 0.81 (Jerrell, 2006).  In addition, the interscale correlation coefficients were in the 
moderate range, from 0.42 to 0.58, indicating a moderate degree of independence among 
the subscales (Jerrell, 2006).  Finally, the Cronbach’s alpha coefficients between the 
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subscale scores and the total score were consistently in the good to very good range, from 
0.77 to 0.88 (Jerrell, 2006).  Thus, the MHSIP Adult Consumer Survey psychometric 
results indicate good internal consistency, moderate test-retest reliability, and good 
convergent validity with consumer perceptions of other aspects of their overall care.  
Participatory Decision Making Scale (PDMS; Kaplan et al., 1996) 
The original PDMS is a three-item scale developed by Kaplan et al. (1996).  It 
requires patients to rate the extent to which physicians used a participatory style during 
their provision of services.  The PDMS measures participatory decision-making style by 
asking patients to rate how often or how much the physician: 1) involves them in 
treatment decisions, 2) gives a sense of control over their medical care, and 3) asks them 
to take some responsibility for their care (Kaplan et al., 1996).  The scale has been found 
to have a Cronbach's alpha of 0.74 in prior research. 
Procedure for Original Data Collection 
Each participating agency created four lists with the names of the consumers 
meeting the previously noted criteria (Salzer et al., 2007).  They were separated by race 
and diagnosis to form the following groups: 1) White and schizophrenia spectrum 
disorder; 2) African American and schizophrenia spectrum disorder; 3) White and Major 
Depression diagnosis; and 4) African American and Major Depression diagnosis.  Once 
the lists were obtained, chart reviews were completed to verify the diagnosis of each 
individual to ensure continued eligibility for the study. The names on each list from the 
participating sites were then randomly ordered.  The participants were then interviewed 
in person by the research team after agency staff had obtained a ‘consent to contact’ 
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form.  Three interviews were completed.  The first interview provided baseline 
information.  The second interview was conducted six months later, and the third 
interview was conducted 1 year later after the initial baseline interview. This study used 
information from the first interview only.  
Analysis of Risk/Benefit Ratio 
Potential Risk to Participants 
The data for this study came from an already completed research project. All of 
the information was de-identified before it was made available for analysis .  Therefore, 
there was no additional potential for risk to the participants.  
Potential Benefit to Participants 
There will be no potential benefit to participants in this study, as this is an 
archival data set.  However, the results of this study will benefit others who have been 
diagnosed with a serious mental illness, such that the mental health professionals working 
with these individuals will help to enhance empowerment and ultimately perceived 
efficacy.   
Potential Benefit to Others 
This study will serve to improve the current understanding of the relationship of 
empowerment on treatment outcomes in an individual with a serious mental illness.  
Specifically, it expands on the current definition of empowerment to provide clearer use 
of the construct.  
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Procedures for Maintaining Confidentiality 
As previously noted, this study utilized data from an already completed research 
project, and was de-identified for the purposes of running statistical analyses that 
heretofore have not been run. Therefore, this study did not risk breaching confidentiality 
of the participants in any way.  
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Chapter 5: Results 
In the current study, three sets of hierarchical regressions were conducted to 
examine the following three questions: (a) Does the working alliance and perceived 
global empowerment predict  patient’s perceived self-efficacy in their interactions with 
their psychiatrists?; (b) To what extent does perceived self-efficacy in interactions with 
psychiatrists, perceived global empowerment, and the therapeutic or  working alliance 
predict patients’ perceptions of inclusion in treatment decision making?; and, (c) What is 
the relative contribution of the therapeutic alliance, perception of global empowerment, 
perceived self-efficacy in interactions with physicians, and inclusion in treatment 
decision making to the individuals’ perceived satisfaction with treatment? 
In addition to the hierarchical regressions just described and those presented later, 
hierarchical regressions were also run with demographics in the first step for each 
hypothesis in order to control for potential confounding variables.  The demographic 
variables included race, gender, diagnosis, socioeconomic status, residential status, 
employment status, and education. Race was broken into two categories, Black or White, 
aspart of the inclusion criteria of the original data set as previously noted. Gender was 
broken into two categories: male or female. Participants’ diagnoses were separated into 
two categories in accordance with the original data set: Major Depression or a 
schizophrenia-spectrum disorder (including schizophrenia, schizoaffective disorder).  
Socioeconomic status was determined by whether the participant received social security 
income (e.g., SSI or SSDI).  Residential status included the presence of homelessness, 
including lifetime experience of homelessness.  Employment status measured whether the 
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individual was or was not employed at the time of the original data collection.  Finally, 
participants’ educational status included the following three categories: High School, 
Less Than High School, or More Than High School.  
Of the total of 396 individuals included in the study, 149 (37.6%) were White, 
while 247 (62.4%) were Black. Two hundred thirty three women were involved in the 
study (58.84%). In addition, 158 individuals had a confirmed diagnosis of Major 
Depression (39.9%) and 238 participants were diagnosed with a schizophrenia-spectrum 
disorder (60.1%).  
Among the diagnostic breakdown, of the 158 individuals with a diagnosis of 
Major Depression, 156 completed the WAI-C-S, 157 completed the ES, 157 completed 
the PEPPI, 153 completed the PDMS, and 156 completed the MHSIP. Of the 238 
individuals diagnosed with a schizophrenia-spectrum disorder, 232 completed the WAI, 
237 completed the ES, 237 completed the PEPPI, 228 completed the PDMS, and 236 
completed the MHSIP. A complete listing of all demographic variables is shown in Table 
1. The means and standard deviations of the dependent and independent variables are 
listed in Table 2.   
The results from the additional regressions accounted for only a very small 
percentage of the variance in the variables of interest. For this reason, the regressions 
with the demographics are not presented in the Results section of this document.  The 
only demographic that demonstrated some contribution, though insignificant, was the 
diagnosis of schizophrenia/schizophrenia-spectrum disorder.  The reason for the result is 
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unclear; however, because of the importance of developing recovery-oriented care for all 
people with SMI, attempts were made to explain the findings in the Discussion section.   
 
 
Table 1 
Demographics of Patient Participants 
Characteristic N % 
Gender   
     Female 233 58.84 
     Male 163 41.2 
Race/ethnicity   
     White 149 37.63 
     Black 247 62.37 
Education
a 
  
     Less than high school 169 43.56 
     High school 123 31.70 
     More than high school 96 24.74 
Employment
b 
  
     Not currently employed 349 88.35 
     Currently employed 46 11.65 
Diagnosis   
    Major Depression 158 39.90 
    Schizophrenia 238 60.10 
SSI Income
c
   
     0 (does not receive SSI) 63 15.95 
     1 (does receive SSI) 332 84.05 
Ever Homeless
d
   
     Has not been homeless at one    
     point 205 51.90 
     Has been homeless at one point 190 48.10 
Note. N = 396. SSI= social security income. 
a
Missing 
demographic data in the Education category: 8 missing. 
b
Missing 
demographic data in the Employment category: 1 missing. 
c
Missing demographic data in the SSI Income category: 1 
missing. 
d
Missing demographic data in the Ever Homeless 
category: 1 missing.  
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Table 2 
Means and Standard Deviations of Dependent Variables 
and Independent Variables 
Measures N M (SD) 
ES 394 2.79 (0.28) 
WAI-C-S 388 5.41 (1.17) 
PEPPI 394 3.72 (0.90) 
PDMS sum 381 7.96 (2.38) 
MHSIP sum 392 17.87 (5.58) 
Note. ES = Empowerment Scale; WAI-C-S = Working 
Alliance Inventory-Client Version, Short Form; PEPPI = 
Perceived Efficacy in Patient-Physician Interaction Scale; 
PDMS sum = Participatory Decision-Making Scale sum 
(sum score); MHSIP sum = Mental Health Statistics 
Improvement Program Adult Consumer Survey (sum 
score). 
 
Preliminary Analyses 
Correlational Matrix  
To explain the relationships between one or more predictor variables and one 
dependent variable, multiple regression analyses are frequently used.  In order to be 
deemed valid, regression models rely on the assumptions of linearity, normality, and 
multicollinearity. To assess for the presence of multicollinearity of variables, correlation 
matrices were run between the independent and dependent variables in this study. 
Tabachnick and Fidell (2001) suggested that correlation coefficients of .90 or higher are 
considered threats to multicollinearity. The data from correlations in this study revealed 
no issues of multicollinearity. The highest correlation coefficient between the WAI-C-S 
and PEPPI measures in this study was .558, considered a moderate correlation between 
CORRELATES OF & CONTRIBUTIONS TO TREATMENT OUTCOMES              78 
 
the constructs of working alliance and perceived efficacy in patient-physician 
interactions. The correlational matrix is shown in Table 3.  
 
 
Table 3 
Pearson Correlations Between Empowerment, WAI-C-S, PEPPI, PDMS sum, and 
MHSIP sum Scales 
 ES WAI-C-S  PEPPI PDMS sum MHSIP sum 
ES  1     
WAI  .256  1    
PEPPI  .359  .558   1   
PDMS sum  .259  .389   .285  1  
MHSIP sum -.268 -.442  -.340 -.258 1 
Note. ES = Empowerment Scale; WAI-C-S = Working Alliance Inventory-Client 
Version; Short Form; PEPPI = Perceived Efficacy in Patient-Physician 
Interaction Scale; PDMS sum = Participatory Decision-Making Scale (sum 
score); MHSIP sum = Mental Health Statistical Improvement Program Adult 
Consumer Survey (sum score). 
 
 
 
 For Question 1, this study used the ES, the WAI-C-S, and the PEPPI, where the 
ES and WAI-C-S were the independent or predictor variables, and the PEPPI was the 
dependent variable. For Question 2, this study used the WAI-C-S, PEPPI, ES, and the 
PDMS, where the WAI-C-S, PEPPI, and ES were the predictor variables, and the PDMS 
was the dependent variable. Finally, for Question 3, this study used the WAI-C-S, ES, 
PEPPI, PDMS, and the MHSIP, where the WAI-C-S, ES, PEPPI, and PDMS were 
independent variables. The MHSIP was the dependent variable. In the current study, 
results demonstrated that these scales have significant reliability. Cronbach’s alphas for 
the scales are reported in the previous chapter.  
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Testing Assumptions 
Tests for normality of residuals and heteroscedasticity were conducted in order to 
determine the presence of homoscedasticity and normally distributed regression residuals. 
Assumptions were examined in two ways: (a) using a residual predicted scatterplot to 
examine for the presence of variance in the spread in residuals for different predicted 
values of the dependent variables and (b) using White’s test (1980).  White’s (1980) test 
was used to examine the functional form of a regression model for potential problems of 
heteroscedasticity and misspecification. In this statistical test, the null hypothesis tests 
whether the regression model’s specification of the first and second moment of the 
dependent variable is correct. Therefore, the null hypothesis then becomes a joint 
hypothesis and asserts that the residuals are independent of the exploratory variables and 
that the regression model has been correctly specified. In the present study, for all 
regressions, residuals were approximately normal, and White’s test showed no significant 
heteroscedasticity. Furthermore, the results indicated that there were no substantial 
violations of regression assumptions. 
Hypothesis 1: PEPPI Hypothesis 
 
 To test the hypothesis that higher scores on the ES and the WAI-C-S would be 
predictive of higher PEPPI scores, multiple hierarchical regression analyses, performed in 
Statistical Analysis Software (SAS), were conducted to determine the relationships.   
In the first hierarchical regression, PEPPI was regressed on ES and WAI-C-S. The 
Intercept term was also included in this and all succeeding regressions used to test the 
hypotheses. In the first step of the hierarchical regression, PEPPI was regressed on 
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Empowerment. Data from 384 participants were used; 12 participants failed to complete 
the questionnaire thoroughly (N = 384). The model produced an R-square of 0.13, which 
was statistically significant, F(2, 383) = 57.06, p < .0001. Empowerment and the 
intercept accounted for 13% of the total variance in PEPPI scores. In the second step of 
the hierarchical regression, WAI-C-S was entered into the model.  The model then 
produced an R-square of 0.36, which was also statistically significant, F(2, 383) = 
108.99, p < .0001. This result indicated that the WAI-CS alone accounted for 
approximately 23% of the total variance in PEPPI.  To further evaluate the predictive 
nature of the independent variables on the PEPPI, the variables were entered into the 
model in reverse order. PEPPI was first regressed on WAI-C-S. The model produced an 
R-square of 0.31, which was statistically significant, F(1, 383) = 174.16, p < .0001.  The 
results indicated that WAI-C-S and the Intercept accounted for 31% of the total variance 
in PEPPI scores.  ES was then added into the regression model in the second step of the 
hierarchical regression, and produced an R-square of 0.36, which was also statistically 
significant, F(2, 383) = 108.99, p < .0001].  The results indicated that WAI and ES 
accounted for 36% of the total variance in PEPPI scores, though the ES appeared to 
account for only 5% of the total variance. Results from the PEPPI hierarchical 
regressions are shown in Table 4.   
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Table 4 
Summary of PEPPI Hierarchical Regression Analyses  
 Regression 1 Regression 2 Regression 3 Regression 4 
Variables β ± SE β ± SE β ± SE β ± SE 
Intercept 0.51 ± 0.43 -0.45 ± 0.38 
1.39 ± 0.18 
*** 
-0.45 ± 0.38 
Empowerment 1.15 ± 0.15 *** 0.75 ± 0.14 *** ----- 0.75 ± 0.14 *** 
WAI-C-S ----- 0.39 ± 0.03 *** 
0.43 ± 0.03 
*** 
0.39 ± 0.03 *** 
      
F-statistic 57.06 *** 108.99 *** 174.16 *** 108.99 *** 
R-squared 0.13 0.36 0.31 0.36 
Note.  N = 396; n = 384; missing data from 21 participants.  PEPPI = Perceived 
Efficacy in Patient-Physician Interaction Scale; SE = standard error; WAI-C-S = 
Working Alliance Inventory-Client Version, Short Form.  *p < 0.05. **p < 0.01. ***p 
< 0.001.   
 
 
Hypothesis 2: PDMS Hypothesis 
 To test the hypothesis that higher scores on the WAI-C-S, ES, and PEPPI would 
be predictive of the higher PDMS scores, multiple hierarchical regression analyses were 
again conducted to evaluate the relationship between the predictor variables of WAI-C-S, 
ES, and PEPPI with the criterion variable PDMS. Two hierarchical regression models 
were run, also using SAS.   
In the first hierarchical regression, PDMS was regressed on ES, PEPPI, and WAI-
C-S.  Data from 374 participants were used; data from 22 participants were missing.  In 
the first step of the regression, PDMS was regressed on ES and PEPPI.  The model 
produced an R-square of 0.11, which was statistically significant, F(2, 374) = 21.92, p < 
.0001. The results from the model indicated that ES and PEPPI accounted for 11% of the 
total variance in PDMS scores.  Empowerment was positively correlated to PDMS (β = 
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16.4, t = 3.34, p = .0009).  PEPPI was also positively correlated to PDMS (β = 6.26, t = 
4.08, p < .0001).  In the second step of the hierarchical regression, the predictor variable 
WAI-C-S was entered into the model.  This model produced an R-square of 0.18, which 
was also statistically significant, F(3, 374) = 25.96, p < .0001.  ES and WAI-C-S 
accounted for 18% of the total variance in PDMS scores.  Empowerment remained 
positively correlated to PDMS scores (β = 14.24, t = 3.01, p < .003). WAI-C-S was also 
positively correlated to PDMS (β = 7.23, t = 5.53, p < .0001). PEPPI did not enter the 
model.   
A second hierarchical regression was conducted, and the predictor variables were 
entered in reverse order to better understand the predictive nature of the variables on the 
criterion variable PDMS.  Data from 374 participants were used to test the model; data 
from 22 participants were missing.  In the first step of the second regression, PDMS was 
regressed on ES and WAI-C-S. The model produced an R-square of 0.173, which was 
statistically significant, F(2, 374) = 38.77, p < .0001].  ES and WAI-C-S accounted for 
17.3% of the total variance in PDMS.  ES was positively correlated to PDMS (β = 15.11, 
t = 3.31, p < .0001).  WAI-C-S was also positively correlated to PDMS (β = 7.7, t = 6.94, 
p = .001).  In the second step of the hierarchical regression, PEPPI was entered into the 
model.  This model produced an R-square of 0.174, which was statistically significant, 
F(3, 374) = 25.96, p < .0001].  Results indicated that PEPPI contributed only 
approximately 0.1% to the total variance in PDMS scores. ES was positively correlated to 
PDMS (β = 14.24, t = 3.01, p = .003). WAI-C-S was also positively correlated to PDMS 
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(β = 7.23, t = 5.53, p < .0001).  PEPPI did not enter the model.  Results from the PDMS 
hierarchical regressions are shown in Table 5. 
 
Table 5 
Summary of PDMS Hierarchical Regression Analyses  
 Regression 1 Regression 2 Regression 3 Regression 4 
Variables β ± SE β ± SE β ± SE β ± SE 
Intercept -13.9 ± 12.8 
-28.13 ± 
12.63* 
-28.71 ± 12.6* 
-28.13 ± 
12.63* 
Empowerment 16.4 ± 4.9 *** 14.24 ± 4.74** 15.11 ± 4.56** 14.24 ± 4.74** 
WAI-C-S ----- 7.23 ± 1.31*** 7.7 ± 1.11 *** 7.23 ± 1.31*** 
PEPPI 6.25 ± 1.53*** 1.19 ± 1.73 ----- 1.19 ± 1.73 
F-statistic 21.92 *** 25.96*** 38.77*** 25.96*** 
R-squared 0.11 0.18 0.173 0.174 
Note.  N = 396; n = 375; missing data from 21 participants.  PDMS sum = 
Participatory Decision-Making Scale (sum score); SE = standard error; WAI-C-S = 
Working Alliance Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy 
in Patient-Physician Interaction Scale;.  *p < 0.05. **p < 0.01. ***p < 0.001.   
 
 
Hypothesis 3: MHSIP Hypothesis 
To test the hypothesis that higher WAI-C-S, ES, PEPPI, and PDMS would be 
predictive of greater overall satisfaction in treatment as measured by the MHSIP, 
multiple hierarchical regression analyses were conducted, performed in SAS, to 
determine the relationships between the criterion variable MHSIP and the following 
predictor variables: working alliance, empowerment, perceived self-efficacy in patient-
physician interactions, and inclusion in treatment decision making. Two hierarchical 
regression analyses were conducted to determine the relative contribution of each of the 
predictor variables to the criterion variable.  
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In the first hierarchical regression, MHSIP was regressed on ES, WAI-C-S, 
PEPPI, and PDMS. Data from 374 participants were used to determine the contribution 
of the variables to the total variance in MHSIP; data from 21 participants were missing.  
In the first step of the regression, MHSIP was regressed on ES and PDMS. This model 
produced an R-square of 0.11, which was statistically significant, F(2, 374) = 23.75, p < 
.0001.  The ES and PDMS accounted for 11% of the total variance in MHSIP.  ES was 
negatively correlated to MHSIP (β = -4.37, t = -4.39, p < .0001).  PDMS was also 
negatively correlated to MHSIP (β = -.04, t = -4.01, p < .0001).  In the second step of the 
regression, MHSIP was regressed on ES, PDMS, and PEPPI.  This model produced an R-
square of 0.16, which was statistically significant, F(3, 374) = 23.16, p < .0001.  ES, 
PDMS, and PEPPI accounted for approximately 16% of the total variance in MHSIP 
scores, and PEPPI contributed approximately 5% of the total variance of MHSIP.  ES 
was negatively correlated to MHSIP (β = -2.92, t = -2.85, p = .005).  PDMS was also 
negatively correlated to MHSIP (β = -0.03, t = -3.10, p = .002).  PEPPI was also 
negatively correlated to MHSIP (β = -1.42, t = -4.43, p < .0001).  In the third step of the 
regression, WAI-C-S was entered into the model.  The model produced an R-square of 
0.23, which was statistically significant, F(4, 374) = 27.59, p < .0001.  ES and WAI-C-S 
accounted for 23% of the total variance in MHSIP scores, and WAI-C-S contributed 
approximately 7% of the total variance in MHSIP.  ES was negatively correlated to 
MHSIP (β = -2.71, t = -2.77, p = .006).  WAI-C-S was also negatively correlated to 
MHSIP (β = -1.64, t = -5.88, p < .0001). PDMS and PEPPI did not enter the model.   
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In order to better understand the contributions of the predictor variables to the 
criterion variable, the independent variables WAI-C-S and PEPPI were entered into the 
model in reverse order.  The first step of the hierarchical regression was the same as in 
the first hierarchical regression of this model.  In the second step of the regression, 
MHSIP was regressed on ES, PDMS, and WAI-C-S.  This model produced an R-square 
of 0.23, which was statistically significant, F(3, 374) = 36.38, p < .0001. ES and WAI-C-
S accounted for 23% of the total variance in MHSIP. ES was negatively related to 
MHSIP (β = -2.99, t = -3.16, p = .002). WAI-C-S was also negatively related to MHSIP 
(β = -1.79, t = -7.40, p < .0001).  PDMS did not enter the model when WAI-C-S was 
entered. In the third step of the regression, MHSIP was regressed on ES, PDMS, WAI-C-
S, and PEPPI. This model produced an R-square of 0.23, which was statistically 
significant, F(4, 374) = 27.59, p < .0001.  ES and WAI-C-S accounted for 23% of the 
total variance in MHSIP scores. ES was negatively related to MHSIP (β = -2.71, t = -
2.77, p = .006).  WAI-C-S was also negatively related to MHSIP (β = -1.64, t = -5.88, p < 
.0001).  PDMS and PEPPI did not enter the model.  Results from the MHSIP hierarchical 
regressions 1 – 4 are shown in Table 6.  Results from the MHSIP hierarchical regression 
5 is shown in Table 7.  
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Table 6 
Summary of MHSIP Hierarchical Analyses 1 – 4 (n = 374)  
 Regression 1 Regression 2 Regression 3 Regression 4 
Variables β ± SE β ± SE β ± SE β ± SE 
Intercept 
32.47 ± 
2.71*** 
33.17 ± 
2.65*** 
36.64 ± 
2.60*** 36.82 ± 2.60*** 
Empowerment -4.37 ± 0.99*** -2.92 ± 1.02** -2.71 ±0.98** -2.99 ± 0.95* 
WAI-C-S ----- ----- 
-1.64 ± 
0.28*** 
-1.79 ± 0.24 
*** 
PEPPI ----- 
-1.42 ± 0.32 
*** -0.39 ± 0.36 ----- 
PDMS sum 
-0.04 ± 0.01 
*** -0.03 ± 0.01** -0.02 ± 0.01 -0.02 ± 0.01  
     
F-statistic 23.75*** 23.16*** 27.59*** 36.38*** 
 R-squared  0.11 0.16 0.23 0.230.11 
Note.  Missing data from 21 participants.  MHSIP = Mental Health Statistics 
Improvement Program Adult Consumer Survey; SE = standard error; WAI-C-S = 
Working Alliance Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy in 
Patient-Physician Interaction Scale; PDMS sum = Participatory Decision-Making Scale 
(sum score).  *p < .05; **p < .01; ***p < .001.   
 
 
 
Table 7 
Summary of MHSIP, 5th Hierarchical Analysis (n = 374) 
 Regression 5 
Variables β ± SE 
Intercept 36.64 ± 2.60*** 
Empowerment -2.71 ±0.98** 
WAI-C-S -1.64 ± 0.28*** 
PEPPI -0.39 ± 0.35 
PDMS sum -0.02 ± 0.01 
  
F-statistic 27.59*** 
R-squared 0.23 
Note.  Missing data from 21 participants.  MHSIP = Mental Health Statistics 
Improvement Program Adult Consumer Survey; WAI-C-S = Working Alliance 
Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy in Patient-Physician 
Interaction Scale; PDMS sum = Participatory Decision-Making Scale (sum score).  *p < 
.05; **p < .01; ***p < .001 
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Chapter 6: Discussion 
The objective of the study was to uncover the relationships between consumer-
reported levels of empowerment and working alliance with their reported perceived self-
efficacy, inclusion in treatment decision making, and treatment outcomes for the purpose 
of providing guidance to provider training and program direction.  This study also sought 
to further the current literature and understanding of the nature and value of assisting 
consumers of behavioral-health services to actively engage in their behavioral-health 
treatment. To study the relationships between the constructs, multiple hierarchical 
regressions were used in order to determine which of several independent variables were 
predictive of the dependent variable. The analyses were conducted in three stages, using 
two regression models for each hypothesis. In each stage, a part of the prediction model 
was tested using both predictor and criterion variables. In the first hypothesis, the 
relationship among overall global empowerment, therapeutic alliance, and treatment-
specific efficacy was examined. The second hypothesis focused on the relative 
contribution of global empowerment, therapeutic alliance, and treatment-specific efficacy 
on the sense of inclusion in treatment decision making. In the final hypothesis, all of the 
previously mentioned process and internal variables were examined to determine their 
relationship with perceived mental-health treatment outcomes. The following discussion 
will review the results that were obtained in this study.  
Study Findings 
 The study found that higher therapeutic alliance and perceived global 
empowerment were significant predictors of greater perceived self-efficacy in 
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interactions with physicians/clinicians. Additionally, it found that having a diagnosis of 
depression versus schizophrenia was a significant predictor of perceived treatment-
specific self-efficacy.  These results suggest when individuals with SMI, specifically 
those diagnosed with depression, are able to develop a greater sense of rapport within the 
therapeutic relationship and simultaneously embody a greater sense of overall 
empowerment, these individuals are more likely to feel more efficacious in asking 
treatment-related questions in their interactions with their physicians.  This finding is 
important to the field because of the growing body of literature that indicates that 
knowledge of options and choices for treatment yields greater positive treatment 
outcomes (Reavley & Jorm, 2011).   
One potential explanation for the greater self-efficacy in individuals with 
depression versus schizophrenia may be related to issues of ability to form helpful and 
well-bonded relationships with others.  Barriers may, in fact, be related to the experience 
of specific symptoms related to a diagnosis of schizophrenia, including the positive and 
negative symptoms of the diagnosis.  For example, an individual experiencing auditory 
hallucinations commenting in a derogatory manner about themselves and others in their 
social environment may then begin to experience a pervasive belief that others are not 
able to be trusted.  As a result, they may believe that others want to bring them harm, 
shame, or other aversive emotions or experiences.  When put in the context of attachment 
theory, which proposes a developmental model of psychological functioning and emotion 
regulation that develops from affectional bonds with close others in the environment of 
care, the experience of symptoms of psychosis becomes the negative life event (e.g., 
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trauma) that prevents the individual from attaching securely to contemporaries as adults 
(Bowlby, 1980; Weinfield, Whaley, & Egeland, 2004).  Analogue samples have 
demonstrated a correlation between self-reported attachment avoidance and paranoia 
(MacBeth, Schwannauer, & Gumley, 2008; Pickering, Simpson, & Bentall, 2008).  
Studies have also demonstrated a relationship between attachment anxiety, attachment 
avoidance, and hallucinations (MacBeth et al., 2008).  Thus, if having a diagnosis of SMI 
and the psychological and experiential sequellae that develop from symptoms of 
psychosis, the likelihood of developing a lasting bond with anyone is very poor, until that 
individual is able to experience a relief in their symptoms and is able to rebuild 
relationships with trusted others.   
Additionally, when considering the pervasive experience of stigma related to a 
diagnosis of schizophrenia, the fact that individuals with schizophrenia tend to experience 
higher levels of stigma may result in lower self-efficacy in relation to their ability to 
recover.  In other words, the negative impact of stigma on sense of ability to enact change 
is greater in individuals who are diagnosed with schizophrenia than with depression.  In a 
study by Kleim et al. (2008), individuals with schizophrenia self-reported experiences of 
stigma as the primary barrier to recovery in schizophrenia, “over and above the amount 
of variance in recovery explained by positive and negative symptoms, depression, insight 
into illness, age, and gender” (p. 486). These findings demonstrated the negative 
influence of stigma on perception of self-efficacy in individuals diagnosed with mental 
illness. Further research is needed to determine why there is a differential relationship by 
diagnosis with treatment-specific self-efficacy.  The results from the current study 
CORRELATES OF & CONTRIBUTIONS TO TREATMENT OUTCOMES              90 
 
highlight that clinicians should be aware that their patients may have different levels of 
self-efficacy given their diagnosis and other possible predictors not tested in the current 
model.  Self-efficacy ought to be addressed and explored in the context of the therapeutic 
relationship to ensure that each individual is able to develop treatment specific self-
efficacy.    
The second set of analyses found that greater reported perceived therapeutic 
alliance and global empowerment were significant predictors of individuals’ perceptions 
of inclusion in treatment decision making, as was hypothesized; however, self-efficacy 
was not predictive in this model. These results indicate that individuals who tend to feel 
more empowered in their lives may also already be predisposed to the ability to develop 
working relationships with their providers, as well as advocate for themselves in the 
patient-physician relationship.  If empowerment is conceptualized as a trait characteristic, 
then individuals who embody higher levels of empowerment may be more likely to 
actively engage with their physicians.  Active engagement in the relationship, in turn, 
may result in their physicians using a more inclusive approach in order to maintain the 
rapport with the more empowered patient.   
Trait characteristics can be further understood by considering locus of control 
theory, expanded upon by Sue’s (1978) discussion that the ability to enact change in 
one’s life circumstances is related to the interaction between internal experiences, such as  
beliefs in one’s ability to enact change, and the greater social world (see also Cattaneo & 
Chapman, 2010).  According to Sue & Sue (2007), perceived locus of control is 
powerfully impacted upon by experienced social forces in a person’s social world and by 
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the individual’s ability to both obtain and exercise power (as cited in Cattaneo & 
Chapman, 2010).  Social forces may include the presence of powerful others and 
regulatory agencies or institutions that regulate behavior and can be seen as the reason 
that groups with less social power tend to report experiencing a more external locus of 
control (Sue & Sue, 2007).  Thus, empowerment also can be viewed as an indication of 
positive adaptation to treatment and resilience among individuals with schizophrenia 
when interacting with their physicians. Further research should be conducted to 
determine other factors that correlate with greater levels of empowerment in individuals 
diagnosed with SMI. 
The positive correlation found in this study between working alliance and 
participatory decision making is not surprising given that shared decision making 
communicates interest in the patient’s needs and wants and is less directive in nature.  
Showing interest and concern and having good listening skills are all variables related to 
developing a positive working alliance. However, further research should be conducted to 
better understand the most effective ways of increasing a physician’s ability to develop 
the therapeutic relationship with consumers with SMI given the observed correlation 
among empowerment, alliance, and the physician’s use of a shared decision-making 
style.      
Of note, PEPPI did not reach statistical significance in both of the regression 
models that were conducted on the PDMS hypothesis, indicating that perceived self-
efficacy in interactions with a treating physician is not a significant predictor of 
perception of inclusion in treatment decision making. This finding contradicts previous 
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research findings and is interesting because the correlational matrix demonstrated only a 
moderate correlation between the two variables. PEPPI’s lack of significance could have 
been obtained for several reasons.  After the other independent variables were included in 
the regression model, treatment-specific efficacy most likely no longer had a significant 
relationship with the dependent variable PDMS.  Therapeutic relationship and perceived 
efficacy in interactions with physicians are conceptually related.  Perhaps the items on the 
WAI-C-S and the PEPPI were too similar in nature.  In other words, any variance in 
PDMS that could have been measured by PEPPI is being explained or accounted for by 
the WAI-C-S because of the moderate correlation found in the correlation matrix between 
PEPPI and WAI.  Therefore, the moderate inter-correlation between PEPPI and WAI-C-S 
is the most plausible explanation for the nonfindings of the PEPPI in the regression 
model.  
A second reason that PEPPI may not have been significant may be because PEPPI 
is not an accurate representation of an individual’s ability to interact with his or her 
mental-health clinician. When considering that beliefs of self-efficacy affect how 
individuals think, feel, behave, and motivate themselves, this task-/context-specific 
variable may not be significant. As has been suggested, having high self-efficacy does 
not compel an individual to enact change (Smits & Bosscher, 1998). In other words, one 
can experience a high sense of control in one’s life but not always feel able to speak up 
about treatment needs when interacting with treatment providers in everyday situations. 
However, if individuals have a strong working alliance with their physicians/clinicians, 
they more likely will feel they are able to speak up for their needs and perceive that their 
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physicians are more inclusive in the treatment decision making.  Additionally, one can 
have high self-efficacy, though not perceive that the provider engages in a shared 
decision-making style, making self-efficacy it less likely to be perceived as related to 
PDMS.  In other words, the treating clinician may not have been using a PDM style, and 
this lack of inclusion is being reflected in the results.   
Results from the final hypothesis regarding treatment outcomes indicated that 
satisfaction with treatment outcomes is strongly correlated to individuals’ perceptions of 
the working alliance, sense of overall empowerment, and perception of inclusion in 
treatment decision making with their treating clinicians.  The correlation found between 
the therapeutic alliance and treatment outcomes in this hypothesis is not surprising when 
considering the constructs measured in the working alliance.  Recall that the measure 
examines the degree to which the client and therapist bond, the degree to which the client 
and therapist collaborate on specific therapeutic activities or tasks, and the degree to 
which the client and therapist agree on the global objectives or goals of the therapy 
(Horvath & Greenberg, 1989).  With the focus of the measure on the bond, the goals, and 
the tasks in the therapeutic interactions, logic permits that individuals who feel closer to 
their therapist would also feel that their therapists include them in treatment decisions.  
Furthermore, these individuals likely are going to report greater outcomes in their 
treatment.  Research studies have demonstrated good evidence to support assertions that 
the quality of the therapeutic alliance is predictive of the therapeutic outcome (Horvath & 
Greenberg, 1989; Marmarosh et al., 2009).   
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Satisfaction was also diagnosis dependent, with individuals diagnosed with major 
depression reporting satisfaction with treatment greater than that reported by individuals 
diagnosed with schizophrenia.  Additionally, this analysis found that satisfaction with 
treatment outcomes was not significantly related to the overall perception of self-efficacy 
in patient-physician interactions. The latter results, similar to those of the preceding 
hypothesis, also contradict previous research findings that treatment- specific self-
efficacy plays an important predictive role in an individual’s overall treatment gains and 
recovery (Maly et al., 1989). These nonfindings in PEPPI significance are likely related 
to the previously listed reasons. Additionally, the result may be influenced by the fact that 
items in the PEPPI are related to a medical setting.  According to the developers of the 
scale, PEPPI is designed to determine the amount of perceived self-efficacy when 
interacting with physicians during medical appointments (Maly et al., 1998).  Possibly,  
the PEPPI is not an appropriate measure to use outside of the medical setting, and 
attempts to use PEPPI to demonstrate predictive value in mental-health treatment 
outcomes is an inappropriate use of the scale. Further research should be conducted to 
determine the validity of using the PEPPI in mental-health research.  In addition, future 
research should also focus on developing a scale that is more specifically related to 
treatment-specific self-efficacy in the mental-health field.   
Results also indicated that individuals diagnosed with depression rated their 
satisfaction with their treatment outcomes greater as compared to that rated by 
individuals diagnosed with a schizophrenia-spectrum disorder. These results are not 
easily interpretable. First, the results may have been obtained because individuals with 
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depression might have been able to achieve greater duration of relief from symptoms or a 
reduction in other psychosocial stressors associated with the diagnosis. The literature 
indicates that 60-80% of individuals diagnosed with depression are able to find 
significant recovery from their symptoms when remaining adherent to treatment 
regimens, including medications and psychotherapy (Smits & Bosscher, 1998). However, 
the literature also indicates that individuals diagnosed with depression experience a high 
rate of relapse, noting that 60 to 80% of individuals who recover do experience a relapse 
within 5 to 10 years (Lee & Murray, 1988; Keller, Lavori, Mueller, Endicott, et al., 1992; 
Kiloh, Andrews, & Neilson, 1988; Surtees & Barkley, 1994).  In this study, participants 
with schizophrenia may not have experienced a decrease in symptoms.  Additionally, 
study participants may have had a generally higher subjective acuity of symptoms and/or 
a possible increase in their experience of symptoms at the time of data collection. As was 
reviewed in a prior section, lower acuity in symptom presentation, as measured by the 
Positive and Negative Symptom Scale (PANSS), has been associated with stronger 
therapeutic alliance and greater treatment outcomes (Frank & Gunderson, 1987; Kay, 
Fiszbein, & Opler, 1987).  However, the association should be considered with caution, 
as the findings on the relationship between symptom severity and treatment outcomes are 
somewhat mixed.  In addition, treatment outcomes may be less favorably perceived by 
individuals with schizophrenia because of similar reasons related to stigma, as previously 
noted.  Future research should focus on the impact that symptom severity and ability or 
skill in forming adult attachments has on treatment outcomes in individuals with 
schizophrenia spectrum and major depressive disorders.  Perhaps, as individuals 
CORRELATES OF & CONTRIBUTIONS TO TREATMENT OUTCOMES              96 
 
experience a remission in their symptoms over time, their perceived satisfaction in 
treatment increases.  Likewise, future research on this focus may demonstrate that as an 
individual gains the skills needed to develop relationships, his or her ability to engage in 
the treatment improves, thus leading to better treatment outcomes.   
Potential Limitations 
Some limitations exist in this study. First, the relationships that were found to 
exist among the variables cannot be considered to be causal. The present study is based 
on a cross-sectional design and prevents the drawing of causal relationships.  Concerning 
the PDMS and MHSIP hypotheses, attention must be drawn to the fact that this study did 
not differentiate between respondents referring to either clinicians or physicians when 
completing the measures.  Instead, eligible participants were instructed to answer items 
on the PDMS and MHSIP scales using their overall impression of experiences with either 
their therapists or their psychiatrists. Therefore, the information that was obtained in the 
analyses cannot and should not be considered representational of either category of 
mental-health professional, but instead of the combination of the two mental-health 
professionals. Therefore, the results, while significant, cannot be easily generalized to 
one specific population of treatment providers, because nonmedically trained clinicians 
may embody characteristics different from those of their medically-trained counterparts 
related to their training (e.g., patient-centered versus the medical model/physician-
directed approaches to treatment). Furthermore, participant age was another variable that 
was not controlled for in this study. Considering that one study found that age in 
individuals with SMI is correlated to positive treatment outcomes (see Solomon et al., 
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1995), the lack of inclusion of this variable in the model for the third hypothesis may 
have left the model underspecified.  
 Finally, the self-report nature of the data that were used has some limitations. 
Confidence in self-report data is limited by a variety of possible biases, and though 
attempts were made to control for the social desirability bias in the procedures of this 
study, participants may have overreported or underreported the presence or lack of items 
on each of the measures used in the study data.  Furthermore, participants’ self-reports 
may have been subject to recall bias as they attempted to respond to questions about 
current treatment.  Regardless of the noted limitations to this study, the results suggest 
significant correlations between sense of overall empowerment, working alliance, 
perceived treatment-specific self-efficacy, and inclusion in treatment decision making in 
perceived behavioral health treatment outcomes.   
Future Directions 
 Training for present and future clinicians has primarily focused on the theoretical 
aspects and approaches to treatment for individuals not diagnosed with SMI, though 
training is slowly changing. The guidelines for transformation in the behavioral-health 
system have been integral in changing the landscape of treatment for individuals with 
SMI.  Several qualitative studies have pointed out that individuals with SMI need 
supportive, hopeful, respectful provider relationships and must feel that they are being 
heard.  Research demonstrates that attempting to provide treatment interventions prior to 
the development of a strong therapeutic relationship is likely to yield frustration on the 
part of both the patient and the clinician, regardless of the presence or absence of SMI.  
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The results from this study suggest that future research should focus on development of 
training for clinicians who provide treatment to individuals with SMI. Specifically, the 
training should include the development of intervention skills necessary to build rapport 
and a strong therapeutic alliance with these individuals.  Interventions should also focus 
on increasing individuals’ sense of overall empowerment, as the results from this study 
suggest that empowerment is a necessary part of recovery from mental illness.   
If global empowerment adds to the sense of inclusion in treatment decision-
making and satisfaction in treatment outcomes, then treatment providers have a 
responsibility to seek to increase empowerment in individuals with SMI.  One helpful 
way to empower these individuals is summed up by the concept of mental health-literacy, 
which includes the ability to recognize a specific mental illness and understand the 
available treatment for a diagnosed disorder (Reavley & Jorm, 2011).  Researchers in 
mental-health literacy suggest that lack of information about one’s specific disorder (e.g., 
lack of knowledge, risk factors, causes, available treatment options, etc.) significantly 
reduces help-seeking behaviors (Jorm, Korten, Jacomb, Rodgers, & Pollitt, 1997; 
Reavley & Jorm, 2011).  In general, before a problem can be addressed, a person must 
first recognize the presence of the problem before seeking help.  Recognition requires, at 
a minimum, a basic foundation of mental-health literacy for individuals seeking to 
recover from their mental illness.  Additionally, assisting individuals with identifying and 
developing personally meaningful goals can increase that individual’s sense of being 
personally invested in his or her treatment.   
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Other interventions that can increase empowerment include specific treatment 
protocols for clinicians/physicians providing the treatment.  Several theoretical models 
currently support and enhance understanding of the importance of relationship building in 
order to assist individuals to prepare to make necessary changes.  These include third-
wave theoretical models of treatment, such as Acceptance and Commitment Therapy 
(ACT) and Dialectical Behavior Therapy (DBT), which focus on increasing an 
individual’s cognitive flexibility, gaining awareness of his or her expressed values, and 
developing behavioral interventions that will allow movement in the direction of his or 
her expressed goals (see Hayes, 2004; Linehan, 1993).  Additionally, significant research 
has been conducted on the Transtheoretical Model of Change, and the Stages of Change 
Theory, two important avenues toward meeting individuals where they are in their 
readiness for change (Prochaska & DiClemente, 1984; Rollnick & Miller, 1995).   Yet 
another model for treatment with a side effect of empowerment is assisting individuals 
with clarifying their values and then working in collaboration with them to connect them 
to community groups that are in line with their expressed values.  
Training should also focus on the important role that empowerment plays in 
individuals’ abilities to have positive gains in their treatment.  Programs should focus on 
implementing practical training on improving clinicians’ ability to empower the 
consumers for whom they are providing treatment.  For example, one leading researcher 
on empowerment and SMI suggests, some strategies that serve to enhance the treatment 
partnerships (Corrigan et al., 2010).  These include (a) using language that endorses 
recovery rather than promoting the idea of poor prognoses, (b) developing treatment 
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plans that utilize a collaborative and shared decision making approach, rather than 
unilateral decision making that is perceived as coercive, and (c) providing effective 
treatment services in the person's community rather than at distant establishments 
(Corrigan et al., 2010).  These strategies are simple at face value.  However, they remain 
central to the necessary transformation of the behavioral healthcare system.  Making 
changes in this manner requires each practitioner to fully understand and embrace the 
idea that all individuals can recover.   
Interestingly, treatment approaches that focus only on the person and the 
treatment relationship are not sufficient (Corrigan et al., 2010). Stigma and discrimination 
remain significant barriers to the kind of community opportunities that are necessary to 
help people attain life goals. Therefore, communities that substitute stigmatizing attitudes 
and discriminatory behaviors with realistic views of psychiatric disability are more likely 
to provide the kind of reasonable accommodations that some people need for work and 
independent living opportunities.  This information can guide treatment providers in 
making purposeful attempts to advocate for inclusion and integration of individuals with 
SMI in the greater community, as community acceptance and integration play a vital part 
in recovery.  In addition, further research should be conducted to determine the predictors 
of empowerment, as this construct, along with the therapeutic alliance, demonstrated the 
most consistent significant relationship with all of the criterion variables, specifically the 
perceived treatment outcomes.  
The findings of the relationship between the empowerment measure and sense of 
self-efficacy in patient-physician interactions are important to the field of psychology 
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because they suggest people may feel empowered in their overall life, but not necessarily 
have the same sense of power and mastery in a very specific context when they are 
expected to interact with their physicians. A lack of treatment-specific self-efficacy may 
be related to the fact that there is already a power differential that already exists between 
the physician and the consumer.  Furthermore, individuals who are already globally 
empowered may also lack the specific skills needed to ask their physicians questions.   
Self-efficacy requires knowledge and the skills to act on this knowledge, and treatment 
providers need to improve their efforts in providing consumers with information about 
medications, empirically based treatment options, and diagnosis, and, in general, in 
demystifying the entire process of treatment.  However, one should note that had WAI-C-
S not been measured in this study, self-efficacy may have been statistically significant in 
the results.  The constructs measured by the WAI-C-S and PEPPI most likely are similar 
enough in nature for this overlap in constructs to result in the PEPPI losing statistical 
significance.  Future studies should be conducted in order to determine how to best 
increase a person’s sense of self-efficacy in interactions with his or her 
physicians/treating clinicians. Specifically, one design of a future study could include 
individuals who identify having greater knowledge about mental illness, diagnosis, 
medications, assertiveness training, etc.  Results from a study design such as this could 
determine if these individuals would then report greater confidence in their abilities to 
interact with their physicians.   
Part of the training of new clinicians must include instruction on developing a 
strong therapeutic alliance while maintaining other core concepts related to the provision 
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of mental-health treatment, such as the theoretical or procedural aspects of training that 
are currently the focus of training programs.  To date, a number of professional 
associations have sought to educate those in the mental-health delivery system about 
adopting a more recovery-oriented approach to the treatment of individuals with SMI.  
All have been formed/are forming as a direct result of the New Freedom Commission’s 
(2003a/b) mandated transformation of the mental health treatment delivery system.  For 
example, SAMHSA, a division of the United States Department of Health and Human 
Services, has developed the Recovery To Practice Initiative, which has awarded grants to 
the American Psychiatric Association, the American Psychological Association, the 
National Association of Peer Specialists, the Council on Social Work Education, and the 
American Psychiatric Nurses Association to develop, pilot-test, and distribute training 
materials for practitioners about recovery and SMI (2009).  These educational and 
training materials are currently being developed by each professional group and are 
expected to be ready for dissemination within the next several years.  Other initiatives 
have been in place for some time and have been integral in the forward movement of the 
recovery-oriented approach (see Tondora & Davidson, 2006).  
Results from this study also indicated that the tendency for physicians to engage 
in a PDM style was significantly correlated with the subjects’ self-reported experiences 
of the working alliance and their own sense of empowerment, as well as with greater 
reported treatment outcomes. The results suggest that clinicians should receive further 
training on better understanding the needs of their patients, particularly the ability to 
accurately reflect and act on their patients’ reported needs, in order to develop greater 
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inclusion in the treatment process.  A discussion of shared decision making regarding 
treatment should also consider the limitations of this approach. For example, patients who 
present as a danger to themselves and others as the result of an impaired mental status, 
thus impairing their ability to care for themselves, do benefit from the temporary partial 
removal of right to autonomy, and this decision may indeed be the responsibility of the 
clinician under current laws (see O’Connell, 2011). In other words, patients who report 
suicidal or homicidal ideation with a plan and intent, patients who are experiencing 
significant symptom-related difficulty managing impulses, or patients who are not able to 
care for themselves because of the presence of acute symptomatology are less likely to be 
able to make treatment decisions that will be beneficial. Physicians and clinicians should 
be trained in screening for the presence of problematic symptom presentations and in 
assessing the level of mental-health literacy individuals have about what is needed in 
order to progress in their recovery.  Additionally, physicians and clinicians could benefit 
from further training in seeking consultation from the appropriate mental-health 
professionals to counter this potential barrier to inclusion in treatment decision making.  
The benefit to inclusion in treatment decision making, as already discussed, is 
greater perceived treatment outcomes. Future research needs to be conducted into the role 
of treatment decision making on treatment gains, adherence, and engagement, and on 
other indicators of subjective and objective functioning.  Being included in the decision-
making process regarding one’s treatment is also indicative of a more person-centered 
approach to treatment that hopefully will result in higher treatment participation and 
objective treatment outcome indicators.   
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Conclusion 
Overall sense of empowerment, the development of a strong working alliance, 
perceived self-efficacy in interactions with treating clinicians, and perception of inclusion 
in treatment decision making are all constructs that are considered essential to the 
provision of effective treatment of individuals diagnosed with mental illness. This study 
sought to determine the relationship among these variables and their abilities to predict 
greater satisfaction with treatment outcomes for the purpose of furthering the field’s 
understanding of how to best shape the provision of services to individuals with SMI. 
Nearly all of the constructs demonstrated significance, with the working alliance, 
empowerment, and the perception of inclusion in treatment decision making predicting 
overall satisfaction with treatment outcomes. Based on this study, future research should 
focus on the development and evaluation of training programs for the clinicians who will 
be providing mental-health treatment to these individuals. To help shape these programs, 
the behavioral-health services delivery system would benefit from new training modules 
for clinicians that will ultimately serve to enhance overall recovery for individuals with 
SMI as they build upon their satisfaction with treatment outcomes.  
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